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Currently, no technique is available to continuously film coat nano-sized drug particles 
with a polymer to produce large amounts of free-flowing coated particles. In this work, 
Eudragit RL 100 and Poly (D, L-lactide-co-glycolide) (PLGA) are chosen as the coating 
polymers; Cosmo 55 (550 nm silica particles), Aerosil 200 (hydrophilic 12 nm silica), 
Aerosil R974 (hydrophobic 12 nm silica) and Griseofulvin (10 µm drug particles) are 
chosen as the host particles. Two novel crystallizers are designed and fabricated to 
continuously coat the host particles with different polymers: solid hollow fiber cooling 
crystallizer (SHFCC) and porous hollow fiber antisolvent crystallizer (PHFAC). 
In the SHFCC-based crystallization/cooling method, the polymer solution 
containing a suspension of submicron particles flows in the lumen of a solid non-porous 
polymeric hollow fiber. Controlled cooling of the polymer solution by a coolant on the 
shell side of the hollow fibers allows for polymer nucleation on the surface of the particles; 
the precipitated polymer forms a thin film around the particles, the thickness of which can 
be varied depending on the operating conditions. In the PHFAC based crystallization 
method, an acetone solution of the host particles containing the dissolved polymer is passed 
through the shell side of a membrane module containing many porous hollow fiber 
membranes. Through the lumen side of the hollow fiber membranes, the anti-solvent water
 
are passed at a higher pressure to inject water jets through every membrane pore in the 
fiber wall into the shell-side acetone feed solution creating an extremely high level of 
supersaturation and immediate crystallization. The host particles get coated by the 
precipitating polymer in the PHFAC module. For the coating of Griseofulvin (GF) drug 
particles, GF first precipitates from the solution in the PHFAC module due to the addition 
of anti-solvent water, subsequently GF crystals get coated by the precipitating polymer. 
Scanning electron microscopy (SEM), transmission electron microscopy (TEM), 
energy dispersive X-ray spectrometry (EDS), laser diffraction spectroscopy (LDS) and 
thermogravimetric analysis (TGA) are all used to characterize the coatings. To study the 
properties of the coated drug crystals, X-Ray Diffraction (XRD), Raman spectroscopy, and 
dissolution tests are implemented. These results indicate that a uniformly coated, free-
flowing product is successfully developed under appropriate conditions by both the 
SHFCC and the PHFAC method; the coated drug particles can be potentially used for 
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1.1  Drug Delivery Systems in Pharmaceutical Industry 
Drug delivery refers to approaches that can transport the drug compound to the human 
body when it is needed to achieve the therapeutic effect. It is often implemented via an 
appropriate drug formulation or medical device. In controlled drug delivery systems, well-
characterized and reproducible dosage forms are utilized to ensure that the rate and duration 
of drug delivery achieves the required concentration in the host. Usually there is a 
concentration range for each drug which provides optimal therapeutic effects: higher 
concentration may cause toxicity whereas a lower one may be therapeutically ineffective. 
Controlled delivery is usually achieved by either dispersing the drug in a polymer matrix 
or encapsulating individual drug particle in a polymeric coating [1]. The polymeric coating 
can also provide protection for fragile drugs (e.g., proteins and peptides) from hydrolysis 
and degradation, for example, by providing protection from stomach acids. The latter is a 
prime example since even small drug molecules such as erythromycin can be irritating to 
the gastric mucosa.  
 The size range of drug particles can vary between micron-sized, sub-micron and 
nanoparticles. Due to their greater solubility, high stability, high carrier capacity, 
incorporation of biodegradable and hydrophobic/hydrophilic substances and 
administration by a variety of delivery vehicles, nanoparticle-based systems have attracted 
considerable attention in controlled release of drugs [2] [3], delivery of anticancer drugs 




vehicles [6] and delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis 
[7], Dense polyethylene glycol coating improved penetration of polymeric nanoparticles 
within brain tissue in cases where the blood-brain barrier is compromised [8]. Polymer-
coated nanoparticles are also being utilized in chemical, electronic, optical and physical 
applications. 
Nanoparticle-based drug delivery systems are also of significant interest in 
controlled release of drugs [9  , tumor-targeted triplex therapy [10  , anticancer drug 
delivery [11  and for enhanced cancer therapy [12 . Important advantages of nanoparticles 
in drug delivery systems also include different ways of administering the drug including 
oral, injection, and inhalation methods. These desirable properties greatly improve drug 
bioavailability and patient compliance by reduced drug administration frequency.  
Lai et al. [13  recently demonstrated that nanoparticles, if sufficiently coated with 
a muco-inert polymer such as lower molecular weight PEG, can rapidly traverse 
physiological human mucus with diffusivities almost as high as those in pure water. This 
finding suggests that it is possible to engineer (coat) nano-sized drug particles to overcome 
the mucus barrier, allowing sustained drug delivery to specific cells in the body at mucosal 
surfaces and provide improved efficacy and reduced side effects for a wide range of 
therapeutics.  
The potential for nanoparticles to revolutionize drug delivery systems is huge. 
However, a number of problems need to be overcome including continuously layering and 
coating nanoparticles with polymeric materials to achieve time release, protecting them 
from stomach acids and being trapped by a mucus barrier, or preventing immune cells 




bloodstream [14 . Nanoparticle surface coating or tailoring can also provide a variety of 
desirable properties in physical, optical, electronic, and chemical applications. 
 
1.2 Polymer Coating Techniques 
A variety of methods have been conventionally employed to coat micron-sized, submicron, 
and nanoparticles with a polymer. Physical vapor deposition, plasma treatment, chemical 
vapor deposition, and pyrolysis of polymeric organic materials are examples of dry 
methods; sol-gel processes, emulsification and solvent evaporation techniques are 
examples of wet methods [15]. Additional methods for polymer coating or encapsulation 
of nanoparticles and ultrafine particles employing supercritical CO2 are: Rapid Expansion 
of Supercritical Solutions (RESS), Supercritical Anti-Solvent (SAS), and Gas Anti-Solvent 
(GAS) processes. These processes [16-19] have many shortcomings such as, very high 
pressures, low solubility of polymers many of which may also lack biodegradability. 
Furthermore these are batch processes and it would be problematic to develop the needed 
drug production capacities. 
 Although fluidized bed-based coating processes can be continuous, there are 
problems due to scale-up difficulties as well as agglomeration of smaller (submicron and 
nano) particles resulting from van der Waals and other inter-particle forces; the polymer 
coating will further enhance the tendency for these particles to agglomerate. 
Conventional batch crystallization devices [20][21] if used for coating will suffer 
from imperfect mixing and non-uniform conditions leading to extreme variability of the 
product. Conventional crystallization/precipitation relies on processes employing cooling, 




addition-based processes, the technique of increasing interest in pharmaceutical processing 
is the use of an impinging-jet mixer, where two high velocity streams are brought into 
contact to effect high nucleation rates, followed by growth in a well-mixed vessel or a 
tubular precipitator (Midler et al., 1994) [22]. However, there are a number of well-known 
shortcomings of this technique. As mentioned earlier, the SAS, GAS and related 
supercritical anti-solvent techniques are batch processes which require very demanding 
experimental conditions.  
Two hollow fiber membrane-based crystallization (SHFCC and PHFAC) 
techniques were developed recently to bypass these problems [23][24]. These two concepts 
were employed in this thesis to develop two continuous techniques whereby micron-size 
particles (dugs or otherwise) having a thin polymeric coating are produced continuously 
from an acetone solution of the drug as well as the polymer used to coat it. Scale-up 
problems in conventional batch crystallizers which are usually stirred vessels include the 
problems of imperfect mixing and non-uniform conditions leading to a broad crystal size 
distribution (CSD). New monitoring techniques [25][26] can lead to better prediction and 
control of the applied supersaturation in crystallizers. However, well-mixed crystallizers 
are intrinsically inclined toward a spectrum of local conditions in time and space and 
consequently a relatively broad CSD. These problems are essentially avoided in the two 
techniques studied here. 
 
1.3  Characterization Methods 
In order to understand the physical or chemical properties of the coated particles, these 




characterization tools is listed below. 
 
1.3.1  Scanning Electron Microscope (SEM) 
A scanning electron microscope (SEM) is a type of electron microscope which can focus 
the electron beams to scan and produce image of the sample in a large magnification. The 
sample was “illuminated’’ by the electrons. Since the wavelength of the electron is much 
smaller than light, they can detect much smaller structures. The wavelength of the electrons 
used in the SEM is usually around 0.5 Å, while the wavelength of visible light is around 
4000 Å. The electrons first interact with the sample’s atoms, then generate and transfer the 
signal that contains various information, for example, the composition of the sample or 
surface morphology. 
Figure 1.1 is the schematic of a typical SEM. The electron beam, which has an 
energy ranging from 0.2 kev to 40 kev, is emitted from the electron gun fitted with a 
tungsten filament cathode. Subsequently the beam passes through the deflector plates or 
scanning coils in the electron column. When the sample interacts with the emitting electron 
beam, the electrons tend to lose energy because of the scattering and absorption of the 
sample. The detector can explore the energy exchange between the sample and the electron 
beam resulting in the reflection of high-energy electrons by elastic scattering. The scattered 
electrons from the sample or secondary electron are collected by the electronic device. 
Once the targeted region of the sample is scanned over by the electron beams, a complete 





Figure 1.1  Schematic diagram of a typical scanning electron microscope [27]. 
 
1.3.2  Scanning Transmission Electron Microscopy (STEM) 
Scanning transmission electron microscopy (STEM) is also a microscopy technique similar 
to SEM. An electron beam is transmitted and interacts with a thin specimen; image of the 
sample can be detected by the sensor and displayed on the computer. Compared to SEM, 
normally the STEM can produce images that have higher magnification and greater 
resolution. Besides, the add-on of Electron energy loss spectroscopy (EELS) and annular 
dark-field imaging can be used to distinguish the polymer coating and the host particle in 
order to identify the density of the coating thickness and the topography of the coating 






1.3.3 Thermal Gravimetric Analysis (TGA) 
Thermal gravimetric analysis (TGA) is a thermal analysis method that can provide the 
physical or chemical information of the sample that is being heated up as a function of the 
increasing time or temperature. Normally TGA is used to determine the material properties 
that exhibit the mass loss due to decomposition of the sample. Figure 1.2 shows the 
schematic diagram of a thermogravimetric analyzer (Pyris 1, PerkinElmer, Waltham, MA) 
being used. The purpose is to obtain the weight loss of the polymer coating on the host 




Figure 1.2  Schematic diagram of thermogravimetric analyzer [28]. 
 
1.3.4  Dynamic Light Scattering (DLS) 




quasi-elastic light scattering) is used for the determination of the particle size distribution 
of small particles suspended in a solution. When light interacts with the small particles in 
suspension, it is scattered in every direction since the particles normally are smaller than 
the wavelength of light (less than 250 nm). The intensity of scattering changes all the time 
because the light source is a laser that is coherent and monochromatic; the fluctuation is 
due to Brownian motion of the small particles which makes the scattering distance 
fluctuating with time. The information containing the time scale of movement of the 
particles will be translated and recorded on the computer. Different types of DLS devices 
have been used in this project due to the different particle sizes and status of the samples.  
 
 
Figure 1.3  Schematic diagram of Beckman Coulter N4 plus analyzer [29]. 
 
Beckman Coulter LS230 is an enhanced laser diffraction particle size analyzer 
which determines the particle size from 0.04 to 2000 µm. Compared to Beckman Coulter 
N4 plus which is a photon correlation spectroscopy analyzer that can measure the particles 
size of 3 nm- 3 µm, it is more suitable for submicron particles rather than nanoparticles. 




provides the flexibility to determine the particle size. Figure 1.4 is the schematic of LS230 




Figure 1.4  Schematic diagram of LS230 analyzer [29].  
 
Sympatec Laser diffraction spectroscope (LDS) coupled with RODOS dry 
dispersion and R1 lens (0.1-35 µm) was used to identify the particle size distribution (PSD) 
of the products collected. The main advantage of this technique is the accuracy of 
determining the real particle size of dry powder sample. RODOS is a universal dry 
dispersing unit which can combination the feeding and the dispersing to achieve a smooth, 
complete dispersion of the sample in order to determine the actual particle size of the 
sample. Figure 1.5 shows a schematic diagram of the Sympatec laser diffraction 
spectroscope that been used for determining the particle size distribution when the sample 





Figure 1.5  Schematic diagram Sympatec laser diffraction spectroscope [30]. 
 
1.3.5  X-ray Diffraction (XRD) and Raman Microscope 
X-ray Diffraction is a technique to identify the crystalline structure of the material and 
provide the information on unit cell dimensions. It has three parts: X-ray tube, sample 
holder and an X-ray detector. A filament is heated in the cathode ray tube to produce 
electrons. When the energy of electron is strong enough to dislodge the inner shell electrons 
of the target material, the X-ray spectra which consists typically of Kα and Kβ, can be 
generated. When X-ray interacts with the rotated sample in the chamber, a detector will 
process and record the X-ray signal if it satisfies Bragg’s law. At the end, the converted 
signal will be the output to a device or computer. Figure 1.6 is the typical diagram of X-
ray Diffractometer that is being used in this thesis. The main application of this XRD is to 
characterize of crystalline materials, determine the unit cell dimensions and measure the 
sample purity. Polymer coated drug particles were analyzed by XRD to identify whether 






Figure 1.6  Schematic diagram of X-ray diffractometer [31].  
 
Raman Microscope (Figure 1.7) is also an effective tool to analyze the molecular 
structure of coated and uncoated particles by the characteristic peaks of Raman shift in 
order to identify whether the coating has damaged the structure of the host crystals. A 
Raman Microscope (DXR, Thermo scientific, Waltham, MA) was applied to the analysis 
of coated/uncoated particles in order to identify whether the coating of drug particles 
affected the drug composition.  
 
 




1.3.6  Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) is a thermoanalytical technique that is widely used 
for the determination of fusion, crystallization events as well as glass transition 
temperatures. Similar to TGA, measurement on a sample is made as a function of 
temperature over time. The basic principle of DSC is as follows. When the sample 
undergoes a physical transformation, heat will need to flow to it than the reference to 
maintain the temperature unchanged. A differential scanning calorimeter shown in Figure 
1.8 was used over a temperature range of 30-250 oC at 10 oC/min heating rate to measure 
the heating profile. 
 
 
Figure 1.8  Schematic diagram of differential scanning calorimeter [33]. 
 
1.3.7  Dissolution Testing 
Dissolution testing is widely used in the pharmaceutical industry to determine the drug 
release information. As a substitute for human studies, well-established dissolution testing 
information can be very useful for drug formulation and manufacturing changes of the drug. 




via a Distek Dissolution tester (North Brunswick, NJ).  
 
1.4  Objectives of this Thesis 
1.   Design and build the hollow fiber devices and the experimental setup for both coating 
techniques: Solid Hollow Fiber Cooling Crystallization (SHFCC) and Porous Hollow Fiber 
Anti-solvent Crystallization (PHFAC). 
2. Select host particles (submicron, nanoparticles and drug particles), polymers, 
appropriate surfactants, solvent and anti-solvent systems for both of the coating methods. 
3.  Investigate a continuous process for polymer coating of different host particles via 
cooling crystallization/precipitation of a polymer solution on submicron and nanoparticles 
in suspension in a SHFCC exchanger. 
4.  Investigate a continuous process for polymer coating of different host particles via 
antisolvent crystallization/precipitation of a polymer on nanoparticles suspended in a 
polymer solution in a PHFAC device. 
5.  Characterize the coated host particles collected from SHFCC and PHFAC process. 
6.  Illustrate the potential for scale-up by operating either one of the two techniques, 
SHFCC or PHFAC at different rates of operation and larger hollow fiber devices. 
 
1.5  Approach 
To overcome the problems of conventional coating methods mentioned in Section 1.2, two 
novel crystallizer designs based on a hollow fiber device were proposed in the thesis: Solid 
hollow fiber cooling crystallizer (SHFCC); Porous hollow fiber antisolvent crystallizer 
(PHFAC). This study has investigated how one can use such devices and techniques to 
continuously coat host particles such as drug crystals which may be submicron particles or 






1.5.1  Solid Hollow Fiber Cooling Crystallizer (SHFCC) 
Figure 1.9 shows a single polymeric hollow fiber whose wall is solid (nonporous).  The 
internal diameter (I.D.) is 420 μm and the outer diameter (O.D.) 575 μm. The polymeric 
hollow fiber is of polypropylene (PP) which has a great deal of chemical, pH, and solvent 
resistance.  One could also employ a variety of other polymers, polytetrafluoroethylene 
(PTFE), polyimide, etc.  Polymers PP and PTFE in hollow fiber form are particularly useful 
since their smooth and non-sticky surfaces do not easily allow accumulation of 
precipitating crystals as long as the liquid is flowing. The polymer used to make the hollow 
fiber must be totally inert in the solution environment. Further a smooth surface is 
necessary to eliminate roughness elements in the wall from acting as possible nucleation 
sites.  
The solution slated for crystallization is made to pass through the bore (or lumen) 
of the solid hollow fiber while a coolant flows on the outside of this fiber, thereby setting 
up heat exchange. If one allows the hollow fiber to be part of a cylindrical heat exchange 
device packed with many such solid wall hollow fibers (Figure 1.10), then many long 
microfluidic channels have been essentially bundled together in one small device; however, 
these channels are circular and the channel dimensions are considerably, almost by an order 
of magnitude, larger than conventional microfluidic channels.  
Zarkadas and Sirkar [34  have experimentally demonstrated that such a 30 cm long 
polymeric hollow fiber heat exchanger (PHFHE) is highly efficient compared to other heat 
exchangers due to the very large heat exchange surface area/volume (1400 m-1) created by 
the polymeric hollow fiber surface area. Larger heat exchangers have been successfully 




from a solution flowing through the hollow fiber bore with the coolant flowing on the shell 
side, the SHFCC was highly efficient for both aqueous and organic crystallizing solutions 
[23 . Examples illustrated include: crystallizing KNO3 from an aqueous solution, salicyclic 
acid from ethanol, and paracetamol from an aqueous solution [36 . The number of crystals 
generated/unit volume was 2-3 orders of magnitude higher, CSDs were much narrower, 
and the mean crystal sizes were 3-4 times smaller than those from conventional mixed 
suspension mixed product removal (MSMPR) crystallizers. The very low temperature 
difference between the SHFCC fiber wall and the crystallizing solution (~1-2 oC) provided 
a far greater control over nucleation/crystal growth process compared to that in a MSMPR 
crystallizer. It is equally valid when one compares the conditions in the bore of a hollow 
fiber to that in a metallic tube in a conventional shell-and-tube heat exchanger.  
In a PHFHE performing as a SHFCC, each hollow fiber acts as a separate 
crystallizer.  It is as if the feed solution has been subdivided into numerous identical fluid 
packets traveling through each hollow fiber bore with the same velocity and under the same 
cooling conditions created by the flowing shell side cooling fluid. Therefore, the scale-up 
problem is minimized which is a major strength of the SHFCC devices. If a few hollow 
fibers get accidentally blocked, the disturbance to the rest of the fiber assembly is minimal 
since in a 2.54 cm diameter module, there may be as many as 90 hollow fibers; in a 5.08 
cm diameter module, there will be 360 fibers. Note that the fiber bore side flow Reynolds 
number is quite low (<500) to achieve the type of heat exchange as well as crystallization 
performances observed.   
Therefore, the pressure drops in the PHFHEs are much lower, as low as 1 kPa/NTU 




heat exchangers. For the same pumping cost, PHFHEs transfer 5-20 times more heat per 
unit volume than typical shell-and-tube heat exchangers; this translates immediately into a 
much more efficient cooling crystallizer. Similar PHFHE devices have been employed here 
for continuous submicron particle coating. 
The hollow fiber I.D. in SHFCC devices studied was 420 μm; therefore a clogging 
problem with nanoparticles or submicron particles is unlikely in SHFCC devices. Suppose 
a high level of nanoparticle agglomeration yields particle sizes ~ 1-2 m; hollow fiber 
membrane devices routinely handle such particles. Any dissolved polymer in the solution 
can precipitate onto nanoparticles present if the temperature is reduced appropriately in the 
SHFCC device. The particle surfaces can also act as nucleation sites for the precipitating 
polymer. If the submicron particles/nanoparticles are present in a significant volume 
fraction, it is unlikely that polymer precipitation will create a network spanning the cross 
section of the tube I.D.  Obviously, this has to be studied vis-a-vis the liquid residence time 
in the fiber bore.  Residence time control however has to be balanced against excessive 
coating of all particles. 
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Figure 1.10  Schematic of solid hollow fiber crystallizer/heat exchanger [23]. 
 
Figure 1.10 shows solid hollow fibers inside the shell-and-tube SHFCC. The 
polymeric hollow fiber of polypropylene can resist chemicals such as dioxane and acetone 
used here; the surface of the nonporous wall of the fiber is smooth and non-sticky so that 
the precipitating polymers/crystals will not stick to the wall as long as the solution is 
flowing. The crystallization solution passes through the lumen side of the hollow fiber; the 
cooling liquid is passed through the shell side extracting heat through the wall so that 
polymer in the solution precipitates onto the surrogate silica particles present in the solution 
flowing through the fiber bore. Eventually, the coated particles flow out of the SHFCC 
along with the solution.  
 
1.5.2  Porous Hollow Fiber Antisolvent Crystallizer (PHFAC) 
Figure 1.11 (a) shows a single porous hollow fiber used for anti-solvent crystallization 
based synthesis of polymer coated host particles. One can use a hydrophilic hollow fiber 
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The inner diameter (ID) and the outer diameter (OD) for this hollow fiber are 600 µm and 
1000 µm, respectively. The fiber wall porosity is 0.75 with pores generally in the range of 
0.2 µm; however, there are pores as large as 1.5 µm. Other types of porous hollow fibers 
may also be used.  
Four alternative PHFAC process configurations can be employed. Figure 1.11 (a) 
shows the feed polymer solution containing the dissolved drug species flowing through the 
fiber lumen side while the anti-solvent permeates from the shell side through the pores into 
the lumen. The shell side pressure is kept at a higher level to maintain a certain permeation 
rate for the anti-solvent. The polymer as well as the drug crystallizes from the solution due 
to the introduction of the anti-solvent through every membrane pore. As will be shown 
later, it appears that the drug crystals are formed rapidly; then they get coated by the 
precipitating/crystallizing polymer molecules in the tube side solution. One can also 
employ a solution of the polymer containing a suspension of the particles to be coated. As 
the anti-solvent permeates, the polymer is precipitated on the particles. 
Figure 1.11 (b) illustrates an exactly opposite scheme. The anti-solvent flowing in 
the tube side at a higher pressure flows into the shell side where the acetone solution 
containing the dissolved drug molecules and the polymer is flowing. Crystallization takes 
place in the shell side with both the drug and the polymer precipitating; the rapidly 
crystallizing drug particles get immediately coated by the precipitating polymer. Two other 
potential operational configurations of the PHFAC technique shown in Figures 1.11 (c) and 
(d) involve passing the feed solution through the membrane pores. However, in these 
configurations, there is an undesirable possibility of precipitation occurring in the pores 





(a)                                                                         (b) 
 
 
(c)                                                                        (d) 
 
Figure 1.11 Porous hollow fiber anti-solvent crystallization (PHFAC) operating approach 
for the permeation of anti-solvent through the pores: (a) crystallization in the tube side; (b) 
crystallization in the shell side. PHFAC operating approach for the permeation of feed 









Figure 1.12 depicts a PHFAC module containing a number of porous hollow fibers 
for continuous synthesis of polymer-coated drug crystals. The anti-solvent flowing through 
the hollow fiber tube side at a higher pressure permeates to the shell side where the polymer 
solution containing the dissolved drug molecules is flowing. Zarkadas and Sirkar (2006) 
[24  have demonstrated that the mixing efficiency of this process is extraordinary. The 
rapid local addition of the anti-solvent through every pore mouth drastically decreases the 
solubility of the drug as well as the polymer in the feed solution; a very high supersaturation 
is created throughout the shell-side cross section at every axial location in the module 
causing precipitation of the drug and the polymer resulting in the production of polymer 
coated drug particles. The suspension of the coated particles along with the excess solution 
and the anti-solvent are pumped out continuously from an outlet of the shell.  
This novel PHFAC device and the process of synthesizing polymer coated drug 
crystals have certain advantages compared to the other anti-solvent crystallizers. There is 
an extraordinarily intense contacting of the anti-solvent and the feed solution everywhere 
in the shell side of the PHFAC module. Since the fractional porosity of the hollow fiber 
wall is around 0.75, a large number of hollow fibers will result in anti-solvent jets 
emanating from all of the pores in the membrane module. Therefore, almost the entire shell 
side will be subjected to an intense contacting due to the very large interfacial area created 
between the two miscible liquid streams. A very high level of supersaturation is created 
throughout the shell side resulting in very rapid crystallization of the drug molecules as 
well as the polymer. The growth of the crystals and the coating thickness will depend on a 




supersaturation created and the time allowed for the growth process to occur which is 
largely determined by the residence time of the shell-side liquid stream. 
Another advantage of the PHFAC device is the high surface area/volume ratio that 
can be achieved if there is a reasonably high packing density of the hollow fiber membranes. 
That will lead to maximization of the rate of production of the coated drug particles and 
achievement of a high product recovery rate. Furthermore, scale-up should be relatively 
straightforward since the number of hollow fibers in a module can be increased or 
decreased according to the needs of production; correspondingly, the module shell diameter 
can be increased or decreased. Theoretically, the larger the number of hollow fibers in the 
tube side of PHFAC module, the higher the rate of production. The morphology and 
dimensions of the coated drug particles are likely to remain the same if the flow rates can 
















CONTINUOUS POLYMER COATING/ ENCAPSULATION OF SUBMICRON 
AND NANOPARTICLES OF SILICA USING A SOLID HOLLOW FIBER 
COOLING CRYSTALLIZATION METHOD 
 
2.1 Introduction 
Continuous polymer coating of nanoparticles is of interest in many industries such as, 
pharmaceuticals, cosmetics, food, and electronics. A polymer coating/precipitation 
technique is introduced here; the goal is to achieve a uniform and controllable nanosized 
polymer coating on submicron particles and nanoparticles in a continuous manner. The 
utility of this technique is demonstrated by coating of 550 nm submicron silica particles as 
well as 12 nm silica nanoparticles (SNPs) with different polymers. Both hydrophilic and 
hydrophobic SNPs were successfully coated. First, the cloud point of an acetone solution 
of the polymer containing a controlled amount of the nonsolvent water was determined by 
an UV spectrophotometer. Then the solid hollow fiber cooling crystallization (SHFCC) 
technique was employed to continuously coat particles with the polymer. A suspension of 
the silica particles in an acetone-water solution of the polymer containing a surfactant was 
passed through the tube side of solid polypropylene hollow fibers in a SHFCC device while 
cold liquid was circulated on the shell side. Due to rapid cooling-induced supersaturation 
and heterogeneous nucleation, precipitated polymers will coat the submicron particles and 
nanoparticles. The thickness and morphology of the coating and the particle size 
distribution of the coated host particles were analyzed by scanning transmission electron 
microscopy (STEM) with electron energy loss spectroscopy (EELS), thermogravimetric 





2.2 Materials and Methods 
2.2.1 Materials and SHFCC Module 
The coating polymers employed were Eudragit RL 100 (copolymer of ethyl acrylate, 
methyl methacrylate and a low content of methacrylic acid ester; Mw, 150,000, (Evonik-
Degussa, Parsippany, NJ) and PLGA (Poly (D, L-lactide-co-glycolide), Mw, 7,000-17,000) 
(Sigma-Aldrich, St. Louis, MO). The surrogate host particles are: Cosmo 55 non-porous 
hydrophilic silica nanoparticles, 550 nm, (Presperse, Somerset, NJ); Aerosil 200 (non-
porous hydrophilic fumed silica with a diameter of 12 nm) (Evonik-Degussa, Parsippany, 
NJ) and Aerosil R974 (non-porous hydrophobic fumed silica with a diameter of 12 nm) 
(Evonik-Degussa, Parsippany, NJ). Acetone, a good solvent for Eudragit RL 100, and 
dioxane, a good solvent for PLGA, were obtained from Aldrich. Sodium dodecyl sulfate, 
used as a surfactant, was purchased from Aldrich. All materials were used as received.  
Figures 1.9 and 1.10 show respectively a single solid hollow fiber and many hollow 
fibers inside the shell-and-tube SHFCC. Two sizes of modules were constructed (Table 2.1) 
to compare the module size effect and number of fibers on the coating capacity, thickness, 
and scale-up.  The shell of both modules was made of fluorinated ethylene propylene 
(FEP)-based polymer tubing containing 23 or 46 solid PP hollow fibers. Both ends were 
potted with an epoxy resin to form a tube sheet. 
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2.2.2 Experimental Methods 
A schematic diagram of the cooling crystallization-based continuous polymer coating setup 
is shown in Figure 2.1. A certain amount of polymer was introduced into a flask containing 
acetone under stirring. After the polymer was fully dissolved in acetone, a given amount of 
DI water, which allows the polymer to precipitate at a predetermined temperature, was 
decanted into the flask. Then host silica particles and the surfactant SDS were added into 
the flask. After about 30 min stirring, the flask containing the well-mixed solution-
suspension was put in a water bath at a constant temperature (45 oC). When the experiment 
was started, the solution-suspension was fed into the lumen side of the SHFCC by a pump 
(Masterflex, model no.7523-20, Cole-Parmer, Vernon Hills, IL) at a rate of 3.5 ml/min. The 
temperature indicated by thermocouple T1 was 45 oC, the inlet temperature of the solution. 
Experiments were generally run for 10-20 min. In a typical run the distribution of various 
components will be in the following proportions: Acetone 20 ml, water 4 ml, silica 0.4 g, 
polymer 2.4 g.   
 
Figure 2.1 Schematic diagram of solid hollow fiber crystallization setup for continuous 







At the same time an aqueous cooling solution of 50% by volume of ethylene glycol 
was circulated through the shell side to cool down the solution in the lumen side from 45 
oC to 5 oC (unless otherwise mentioned) to initiate crystallization in the lumen side of the 
hollow fibers. A chiller (Polystat CR250WS, Cole-Parmer, Vernon Hills, IL) cooled the 
glycol solution to -9 oC in the shell side. The solution containing the coated particles 
coming out of the hollow fiber module at around 5 oC (T2) (unless otherwise mentioned) 
is subjected to two alternative treatments discussed below. 
             Two methods were used to collect samples of coated particles from the polymer 
solution leaving the cooling crystallizer/precipitator. Method 1 employing centrifugation 
involves collecting the solution from the outlet of the crystallizer-precipitator in a 
centrifuge tube. After 1 min of centrifugation, the supernatant liquid was decanted leaving 
the product particles coated by polymer. The particles were subjected to vacuum drying 
and used for further characterization. 
The second method employs filtration. After the coated particles and the solution 
came out of the SHFCC outlet, a vacuum filtration device was employed to collect the 
sample. This device allowed the solution containing the coated particles to pass through a 
microfiltration system (Omnipore Membrane, PTFE (Cat.No. JHWP09025),  0.45 µm pore 
size, 90 mm filter diameter, Millipore, Billerica, MA) and remove most of the solution 
leaving behind on the filter paper the coated particles; the cake on the filter paper 
containing the coated particles was collected for post-treatment and further characterization. 
These two methods, namely, centrifugation and filtration, as well as the various post-
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Figure 2.2 Procedure to obtain coated particles from the SHFCC device illustrating various 
post-treatment methods. 
 
 To get free-flowing particles, an additional post-treatment method was developed 
for both filtration and centrifugation. After filtration, particles remained on the filter paper 
and formed a “cake.” The cake on the filter paper was then placed into DI water under 
sonication for about 30 s to break-up loose agglomerates. The solution containing the 
dispersed particles was then decanted onto an aluminum dish and subjected to vacuum 





Post treatment sonication was also done after centrifugation. After the supernatant 
liquid was decanted, instead of collecting particles from the residue inside the centrifuge 
tube some water was added to the tube and the tube was subjected to sonication for about 
30s to break-up the agglomerates. The supernatant liquid was poured out and the 
centrifugation process was repeated once more to remove any excess solution. The particles 
were then decanted into an aluminum dish and subjected to vacuum drying. 
 
2.2.3 Cloud Point Determination of Various Solutions 
Before undertaking coating experiments in the SHFCC, it is necessary to measure the cloud 
point of the solutions of the polymers Eudragit RL 100 or PLGA. There are two main ways 
of determining the cloud points of polymeric solutions, either by a UV spectrophotometer 
or by a refractometer. A Cary 50 UV spectrophotometer (Agilent, Santa Clara, CA) having 
a temperature controller module was used in the present study. By identifying the 
absorbance or transmissivity of the solution in the visible wavelength range (550-800 nm), 
the cloud point can be easily determined. 
  The procedure followed for determining the cloud point of the binary system of 
polymer in an organic solvent is as follows: 
1. From the specification document in Cole-Parmer[37], the concentration of Eudragit in 
the solution at the cloud point temperature of 25 oC should be around 0.2 g/ml. To locate 
the cloud point concentration accurately, twelve samples of this polymer solution were 
prepared; the concentrations were 0, 0.14 g/ml, 0.16 g/ml, 0.18 g/ml, 0.20 g/ml, 0.24 g/ml, 
0.26 g/ml, 0.28 g/ml, 0.30 g/ml, 0.32 g/ml, 0.34 g/ml and 0.36 g/ml. 
2. A baseline correction was run in the UV spectrophotometer in which pure acetone was 
chosen as the baseline to reduce the impact of acetone; after scanning the peak, the 
characteristic peak of Eudragit RL 100 was found at a wavelength of 335 nm. 




4. A concentration of 0.16 g/ml was selected as the cloud point at room temperature since 
its absorbance is very low and yet from the turbidity of the solution, the sample solution of 
0.16 g/ml concentration is at the edge of becoming cloudy.   
5.  This sample was used to develop temperature vs. absorbance plot and compare with the 
concentration vs. absorbance plot to get the relationship between temperature and 
concentration. 
The cloud point temperature of the ternary system of polymer/solvent/water was 
also determined. Eudragit RL 100 was first dissolved in acetone under continuous stirring; 
then a certain amount of water was added and the solution was heated up to 50 oC for 30 
min. After that, the cuvette containing solution was slowly cooled in steps of 1 oC per min. 
The cloud-point temperature was taken as the temperature at which the transmissivity of 
the solution decreased sharply and the solution changed from clear to turbid. A similar 
procedure was followed for a solution of PLGA in dioxane and water. 
Transmissivity can also be used to determine the cloudiness of solution especially 
when the characteristic peak for polymer is not obvious or overlapping with the solvent if 
using an absorbance based determination. The higher the transmissivity % in the 
spectrophotometer reading for a wavelength ranges from 550 to 800 nm, the clearer the 
solution. In this case, the solution which has undergone precipitation will have relatively 
low %T (normally under 20%); so %T < 20% is defined as cloudy and %T > 80% as clear. 
 
2.2.4  Characterization of Submicron Silica Particles 
Due to the limitation of resolution of a scanning electron microscope (SEM), relatively 
large 550 nm diameter COSMO 55 (JGC Catalysts and Chemicals Ltd, Somerset, NJ) 
nonporous spherical hydrophilic silica submicron particles were employed to act as the 
initial surrogate drug particles in the experiments reported here. 




employed for simple morphological observations. Dry coated particles were attached on 
the top of the pin stub mount. To examine the coating covering the submicron particles, it 
is necessary to coat this sample with carbon to make the sample conductive enough to get 
a clear surface structure picture since charging may occur when the specimen has poor 
electrical conductivity, causing distorted or deformed pictures. 
A 200 kV Schottky field emission (JEOL JEM-2010F, Peabody, MA) analytical 
transmission electron microscope (TEM) was used for a more thorough analysis of the 
samples.  Z contrast related high angle dark field images of the coated silica spheres were 
collected under Scanning transmission electron microscopy (STEM) mode to visualize the 
coating surrounding each individual sphere.  The probe size of the electron beam is 1 nm 
so an accurate thickness can be determined from the STEM image directly. Energy-
dispersive X-ray spectroscopy (Model 7246, Oxford Instruments, Concord, MA) provided 
the distribution of the elements on the surface of the nanoparticles.  
A thermogravimetric analyzer (Pyris 1, PerkinElmer, Waltham, MA) was used to 
determine the amount of coating on the sample particles so that the coating thickness can 
be calculated by weight loss during heating. Laser diffraction spectroscopy (Vibri, 
Sympatec, Clausthal-Zellerfeld, Germany) was used to analyze particle size distribution 
and any agglomeration. 
 
2.3 Results and Discussion for Coating of Submicron Silica Particles 
The results of cloud point studies for a number of binary and ternary systems are considered 
first. Then the various pre-treatments and post-treatments of the particle coating system are 





2.3.1 Cloud Point for Polymer/solvent Binary System  
The concentration vs. absorbance data for acetone solution of Eudragit RL 100 at 25 C are 
shown in Figure 2.3 (a). The cloud point data for PLGA/ dioxane are similar to those for 
Eudragit RL 100/ acetone in that the transmissivity of both solutions is around 100% 
(Figure 2.3 b and c); the solution remains clear with no precipitation-based particles 
appearing with a variation in temperature. That is because the cloud point temperature for 
both of these polymers dissolved in a pure solvent is very low; therefore it is difficult to 
have precipitation due to a temperature drop under mild conditions (0 oC to 50 oC). It has 
been suggested[38] that when dissolving PLGA/Eudragit RL 100 into dioxane/acetone, 
addition of a little water decreases the solvation power of the solvent. The solution will 
turn from clear to cloudy depending on the temperature change. Therefore, one can also 
adjust the cloud point of the system by adjusting the amount of water added. 
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Figure 2.3  (b) Transmissivity at different temperatures of 10 wt% Eudragit RL 100/2.5 
ml acetone solution; (c) Transmissivity at different temperatures of 10 wt% PLGA/2.5 ml 
dioxane solution. (Continued) 
 
2.3.2  Cloud Point for Polymer/solvent/water Ternary System 
A limited amount of antisolvent such as DI water was added to the solution containing 
Eudragit RL 100 to increase the cloud point temperature at the same polymer concentration. 




less polymer will be in solution if a little DI water was added; further the solution viscosity 
will be lower making it easier to flow. A few different concentrations of water in the ternary 
system of polymer/solvent/water have been tested under different temperatures. The results 
are provided below for the two polymers studied. 
 
2.3.3  Eudragit RL 100 
Different concentrations of Eudragit and the amount of water added in a 
Eudragit/acetone/water ternary system have been studied under different temperatures. 
Figures 2.4 and 2.5 illustrate the behavior of one such solution; Table 2.2 provides a 
summary of the cloud point temperatures observed for three different compositions of 
acetone/water. Since 15 oC is a modest temperature and was easy to achieve, a volume ratio 
of 2.5/0.5 for acetone/water was selected to obtain the transmissivity vs. wavelength plot 
at a few temperatures as shown in Figure 2.4; Figure 2.5 illustrates how transmissivity 
decreases with temperature for a few wavelengths.  
 
Table 2.2 Cloud Point Temperatures vs. Different Ratios of Acetone/water in Eudragit 
RL100 Solution 
 
Ratio of acetone/water(ml/ml) Cloud point temperature of 10 wt% 









Figure 2.4 Transmissivity of 10 wt% Eudragit RL100 /2.5 ml acetone/0.5 ml water 
solution vs. wavelength at different temperatures. 
 
 
Figure 2.5 Transmissivity of 10 wt% Eudragit RL100 /2.5 ml acetone/0.5 ml water 
solution vs. temperature for a few wave lengths. 
 
2.3.4  PLGA 
Different concentrations of PLGA and the amount of water added in the ternary system of 












































experiments with Eudragit, the change from clear to cloudy status is easier to see through 
visual observations or transmissivity in UV.  
Figure 2.6 provides a graphical summary of cloud point temperature vs. ratio of 
dioxane/water for PLGA. A ratio of 2.5/0.5 (dioxane/water) for 10 wt% PLGA solution or 
2.5/0.56 for 5 wt% PLGA solution can be chosen for these experiments since a temperature 
around 20 oC is a modest temperature and easy to achieve.  
 
Figure 2.6 Cloud point temperatures vs. different ratios of dioxane/water in PLGA 
solutions. 
 
2.3.5 Variations in Feed Solution Conditions (Pre-treatments) 
By adjusting the feed solution conditions, such as adding different amounts of water, 
different amounts of silica, adding a surfactant, and changing the residence time, the 
coating results are seen to be very different. As already pointed out, the cloud point 
temperature of the two polymer solutions will change from clear to cloudy at higher 
(therefore more easily realizable) temperatures when adding different amounts of water. 


























   Particle agglomeration can be reduced by the addition of a surfactant, sodium 
dodecyl sulfate, to the polymer solution. SEM photographs of coated particles with or 
without the addition of surfactant are shown in Figure 2.7. With the addition of a surfactant 
(Figure 2.7 (b)), the dispersion of the coated particles is much better as compared to those 
without the surfactant (Figure 2.7 (a)). The critical micelle concentration (CMC) of sodium 
dodecyl sulfate in pure water at 25 oC is 0.0082 M; therefore the concentration of SDS 
cannot be too high to prevent formation of micelles which can accelerate agglomeration.  
 
    
(a)                                                                        (b) 
Figure 2.7 SEM photographs of coated particles: (a) without surfactant; (b) with surfactant 
(surfactant concentration 0.0035 M). 
 
Figure 2.8 shows the weight loss (percentage) of the coated particles obtained from 
TGA experiments using different amounts of silica added to Eudragit RL 100 solution. 






Figure 2.8  TGA and EDS results for different amounts of silica addition. 
 
The TGA results indicate that with more silica added to the solution, the weight 
loss % is less which implies that the coating thickness around the particles is lower. When 
the amount of silica added exceeds a certain level (over 0.8 g), the coating thickness no 
longer decreases and remains relatively constant. Thus, both a too low or too high a silica 
concentration is undesirable. 
Too low a silica concentration will make the coating thickness on individual 
particles larger; too high a concentration will have little effect on the coating thickness, 
increase the pressure drop, and could result in the possibility of clogging of the lumen of 
hollow fibers. As seen in Figure 2.8, the EDS results reinforce those obtained from the 
TGA. In these experiments when the amount of silica particles added was over 1.6 g per 
20 ml of acetone there was a tendency for clogging.  
The residence time is also critical for submicron particle coating; a longer residence 
time will lead to more polymer precipitation and a thicker coating. Variation of residence 









































shows TGA and EDS results corresponding to suspension flow rates of 1, 5, and 10 ml/min, 
respectively; these flow rates correspond to residence times of 76.2, 15.2 and 7.62 s 
respectively. The TGA results show that as the flow rate increases, the weight loss % 
decreases which indicates that the coating thickness decreases when the residence time 
decreases. EDS results support the same conclusion. 
 
 
Figure 2.9  TGA and EDS results for coated submicron particles for different residence 
times. 
 
Figure 2.10 shows SEM micrographs of coated particles for two different feed flow 
rates employed for Figure 2.9. Polymer coating on the submicron particles is seen to be 
less thick when the flow rate is increased, i.e., residence time is lowered; agglomeration 
between the particles also appears to decrease as the feed solution flow rate increases. It is 
worth noting that the outlet temperatures for the different flow rates studied were only 
slightly different. It is not expected that there would be a substantial effect of the very 
minor difference in outlet temperature on the coating since the temperature is very low 




































    
(a)                                                                            (b) 
Figure 2.10  SEM photographs of coated particles for different feed flow rates: (a) 1 
ml/min and (b) 10 ml/min. 
 
2.3.6  Methods for Recovering Particles (Post-treatments) 
A number of post-treatment strategies were explored including improved vacuum filtration 
speed, sonication after filtration and centrifugation.  These are considered one by one below. 
The thickness of the coating on the particles was reduced by incorporating a vacuum 
filtration device that can increase the filtration rate. Using this filtration device, the 
filtration rate was increased substantially by enhancing the vacuum level from 1 in Hg to 
5 in HG and up to 16 in Hg so that the excess polymer solution would not stay in contact 
with the particles to form a thicker coating. This is significant since in these experiments 
the duration of vacuum-driven filtration for example at 1 in Hg was 8 min whereas that for 
16 in Hg was 5 min. The results of the enhanced vacuum filtration are shown in Figure 
2.11 and Table 2.3. The SEM, TGA, and EDS studies all indicate that the faster the 
filtration rate, the thinner the coating. Particle agglomeration is also much less because the 
polymer solution remaining on the filter paper is extracted before it can form an additional 




lead to agglomeration. Since the filtration rate was found to be critical, all subsequent 
experiments were run at the highest filtration rate (16 in Hg). 
 
    
(a)                                                                       (b) 
Figure 2.11  SEM photographs of coated particles at different filtration rates: (a) slow--1 
in Hg; (b) fast--16 in Hg. 
 
 
Table 2.3 TGA and EDS Results for Coated Submicron Particles Under Slow and Fast 
Filtration Conditions 
 
Vacuum Level 1 in Hg 16 in Hg 
TGA Weight loss % 44.9 17.8 
EDS  Carbon % 37.0 31.2 
 
              Previous experimental methods discussed the use of post-treatment sonication 
after both filtration and centrifugation as a means of producing free-flowing particles. 
Experimental results of Eudragit RL 100 coated particles obtained using sonication after 
fast filtration are shown in Figure 2.12 and compared to those without the sonication post-
treatment. There is almost no excess polymer on the particles in Figure 2.12 (b) compared 
with those in Figure 2.12 (a) and agglomeration between particles is less than that in Figure 
2.12 (a). By using this post treatment method, the products were free-flowing rather than 




   
                                 (a)                                                                   (b) 
 Figure 2.12 SEM photographs of Eudragit RL 100 coated particles (a) without post 
treatment after filtration and (b) with post treatment after filtration. 
 
Sonication was also used as a post-treatment after centrifugation. Similar to the 
results obtained by adding sonication after filtration, free flowing particles were also 
obtained by adding sonication as a post treatment after centrifugation.   
 
2.3.7  Thermogravimetric Analysis of the Submicrometer Particles 
Thermogravimetric analysis (TGA) allows measurement of the change in particle mass as 
a function of time by increasing the temperature of the sample continuously. Samples of 
dry, coated particles and dry, uncoated Cosmo 55 silica particles were analyzed by TGA. 
The temperature in the TGA was increased at a rate of 10 oC/min until it reached 550 oC. 
During this period, Eudragit RL 100 polymer coating decomposed as a result of heating 
while the mass of the uncoated silica remained almost unchanged as seen in Figure 2.13. 
The solid line shows that the weight % of the coated particles was reduced from 100% to 
85%, which means that the 15% weight loss was due to decomposition of the polymer 





Figure 2.13  TGA micrographs of uncoated and Eudragit coated submicron silica 
particles subjected to post treatment methods after filtration. 
 
To estimate the thickness of the coating, it is assumed here that the polymer is 
evenly coated on the spherical submicron particles of radius r and forms a uniform layer. 
The equation governing the relation between the mass of the polymer and the mass of the 
particles is 



















   
                                    (2.1) 
The coating thickness h can be calculated as 
                          
1/3(1 / )Silica PolymerPolymer Silicah r m m r                             (2.2) 
where mSilica and mPolymer are the mass of the particles and polymer, respectively. The 
densities of the host particles and polymer are ρSliica (=2.65 g/ml) and ρPolymer (=1.1 g/ml), 
respectively. Using the results from the TGA, the coating thickness for the submicron 






















2.3.8  Scale-up Using a Larger SHFCC Module 
Scale-up can be achieved by simply using a larger module containing for example double 
the number of hollow fibers, 46 instead of 23 (see Table 2.1). The 25 mm diameter filter 
paper used with the smaller module was replaced by a 90 mm diameter filter paper so as to 
be able to handle a larger amount of product. Since the number of fibers inside the SHFCC 
module was doubled, the flow rate was also doubled without affecting the residence time, 
i.e., the velocity in each hollow fiber remains the same. Therefore the larger module should 
produce particles having a coating similar to that from the smaller module. Coated particles 
collected from both modules, large and small, (all other conditions are the same: 0.4 g silica, 
16 inHg-based filtration speed) were characterized by TGA. The coating thickness of the 
particles calculated from TGA results was 33.1 nm for the large module and 33.3 nm for 
the small module. It should be noted that the coating thickness calculated from the TGA is 
an idealized value that assumes the coating on the particles to be perfectly uniform with no 
excess coating between the silica particles.  
 
2.3.9   Laser Diffraction Spectroscopy 
Sympatec Laser diffraction spectroscopy (LDS) coupled with RODOS dry dispersion and 
R1 lens (0.1- 35 µm) was used to identify the particle size distribution (PSD) of the 
products collected; most importantly, it can identify the amount of agglomeration present 
in the coated particles. A dry powder of particles coated in the small module was tested 
under different pressures (0.5 bar to 3 bar) to determine the average particle size. With an 
increase of the pressure, the powder exhibited a reduction in particle size until a plateau 
was observed. After the pressure reached 3 bar, the particle size did not decrease as the 




default primary pressure (PP) was set as 3 bar when measuring the PSD of the samples in 
Figure 2.14.  
 
  
Figure 2.14  Particle size distribution for uncoated and Eudragit coated submicron 
particles from both the small and large modules.  
 
          The LDS analyzer was used to measure the PSD of uncoated Cosmo 55 silica, 
Eudragit coated Cosmo 55 silica particles from the small module, and Eudragit coated 
Cosmo 55 silica particles from the large module. Table 2.4 shows that the Sauter mean 
diameter (Ds) of the 3 samples are 640 nm, 1310 nm and 1250 nm, respectively. This 
indicates that the coated particles were somewhat agglomerated, forming mostly doublets 
and perhaps some triplets. After scale-up, the mean size of the coated particles from the 
large module is similar to that from the small module. However, there appears to be some 
difference in the extent of agglomeration of the coated particles obtained from the smaller 
module and the larger module (Figure 2.14). The coated particles go through a number of 
post-treatment steps after discharge from the SHFCC device. Any minor variation in these 




























Table 2.4  Particle Size for Uncoated and Coated Submicron Particles 
 
 Sauter mean diameter (µm) 
Uncoated particles 0.64 
Coated particles with small module 1.31 
Coated particles with large module 1.25 
 
2.3.10  Scanning Transmission Electron Microscopy (STEM) 
The particle coating thickness and morphology can be much more precisely determined by 
TEM-STEM analysis which is used to check whether the coating thickness is in accord 
with the TGA results and also if it is uniform. Figure 2.15 (b) shows a photograph of a 
single coated particle under optimized conditions (0.4 g silica, 2.5 cc/min flow rate, 
surfactant concentration 0.0035 M, 4 ml water added to 20 ml of acetone, sonication post 
treatment after filtration at 16 inHg-based filtration rate, small module). The bright area is 
the silica particle and the transparent grey ring represents the polymer coating. From Figure 
2.15, it is easy to see that a uniform, thin coating is covering the particle, while for uncoated 
silica particle shown in Figure 2.15 (a) no transparent ring is seen. Based on the scale bar, 
the thickness of the coating around the single submicron particle can be estimated to be 





(a)                                                                      (b) 
Figure 2.15 STEM micrographs of (a) uncoated submicron particles and (b) coated 
particles under optimized condition. 
 
Figure 2.16 shows the signal profile of various elements (carbon, silicon and 
oxygen) in the coated nanoparticle shown in Figure 2.15 (b). The probe detects various 
elements in the particle from the surface to the interior. The point at 0.022 µm in the x-axis 
is the surface point of the coating; the point at 0.05 µm is the coating end point and the 
beginning of the surface of the silica particle. The coating thickness can then be estimated 
as 0.028 µm or 28 nm.  
 




2.3.11   PLGA Coated Submicron Size Particles 
Coating the silica particles with PLGA was also studied in the SHFCC device but not as 
extensively as with Eudragit. Therefore, only one figure is shown; it indicates that PLGA 
can also be coated onto the silica particles in the SHFCC device. Figure 2.17 (a) shows an 
SEM image of silica particles in a dioxane solution of PLGA before precipitation; Figure 
2.17 (b), (c) and (d) show the SEM images of coated particles after the suspension was 
passed through the SHFCC and precipitation occurred. 
 
   
(a)                                                                  (b) 
 
    
(c)                                                                 (d) 
Figure 2.17  SEM photographs of solutions with PLGA and submicron particles (a) before 






Clearly, there is no coating in Figure 2.17(a); however Figure 2.17(b) shows a 
uniform polymer coating covering the particles. This result is in accord with the EDS result 
that shows a % carbon  of 21.6 after post-treatment using fast filtration (16 in Hg), 
confirming that PLGA can also be used to coat the particles by the SHFCC method. It 
appears that the coating method developed is quite general and may be used with a variety 
of polymers; PLGA being biodegradable is an especially useful example since it is widely 
used in pharmaceutical industry. 
 
2.3.12 Effect of Operating Parameters 
It is useful to briefly summarize here the effects of various operating parameters in this 
technique one by one. 
Residence time: The residence time in the hollow fiber device containing a certain 
number of hollow fibers having a certain I.D. and length is determined by the volumetric 
flow rate of the coating suspension; the higher the volumetric flow rate, the shorter is the 
residence time. From the TGA and EDS measurements it is clear that a longer residence 
time will lead to a higher amount of polymer precipitation as well as enhanced bridges 
between neighboring coated silica particles and agglomerates. 
Lumen-side exit temperature: Other conditions remaining constant, the lumen-side 
exit temperature is controlled by the inlet temperature of the cooling liquid on the shell 
side. A lower temperature will lead to higher precipitation and thicker coating. 
Polymer concentration: Higher polymer concentration will tend to enhance the 
coating thickness and the extent of bridging between neighboring particles and 
agglomerates. However, a higher concentration will also have other deleterious effects: 




which will affect the processing capacity; the chances of clogging of the hollow fiber bore 
will increase. 
Post-treatment time: Among the various post-treatment steps, the collection time, 
the filtration time and the centrifugation time are important in the sense that the coated 
submicron particles are in contact with a solution containing the polymer which is 
precipitating. Therefore, it is important to reduce the duration of various post-treatment 
steps especially when there is a volatile solvent namely, acetone, which will continue to 
evaporate and increase the polymer concentration in solution. 
 
2.4 Results and Discussion for Coating of Silica Nanoparticles (SNPs) 
After the cloud point measurements of the Eudragit/acetone/water solution were completed, 
attention was focused on coating of silica nanoparticles (SNPs) conducted in SHFCC 
modules of two sizes and characterizing the coatings so obtained. The characterization of 
the coatings was carried out after undertaking post-treatment steps mentioned earlier.  
The amount of SNPs plays an important role in polymer coating using the SHFCC 
method since the precipitated polymer will coat every silica particle due to heterogeneous 
nucleation. It is expected that the higher the amount of silica addition, the higher is the 
amount of polymer that will be precipitated.  
The coated SNP samples obtained after post-treatment steps of filtration, sonication, 
and vacuum drying were analyzed by TGA to determine the relationship between the 
average coating thickness on a SNP and the amount of silica added in the feed solution-
suspension. It is useful to specify first the conditions used to obtain the coated SNPs which 




used to produce coated particles and the results compared vis-à-vis their effective coating 
thicknesses. For both modules, the operating conditions were kept the same: 0.1g SNPs, 
20 ml acetone, 0.025g SDS, 2.4g Eudragit RL 100 and 4ml DI water. The only difference 
between the two modules was the number of hollow fibers. To maintain the same residence 
time for precipitation in both modules, a feed flow rate of 4 ml/min was maintained in the 
large module which was twice that in the small module (2 ml/min). Details of the results 
from TGA are provided below.  
Figure 2.18 shows the observed weight loss results for uncoated and coated SNPs. 
The dotted line indicates that pure Aerosil 200 SNPs underwent hardly any weight loss 
during heating. However, both solid lines for the coated SNPs show considerable weight 
loss due to the decomposition of the polymer coating. The mass losses of coated particles 
from the large and smaller modules are estimated to be 60% and 55%, respectively; these 
values are quite close to each other. This result suggests that scale-up of the coating device 
and process may be easily implemented by maintaining the same residence time in 
SHFCC modules of different sizes having different numbers of hollow fibers. 
If one assumes that the polymer coating was evenly spread over all SNPs and the 
particles are assumed spherical, the relation between the coating thickness h of the mass of 
the polymer and the silica nanoparticle of radius r can be deduced from equation (2.1) 
where mSilica and mPolymer are the mass of the nanoparticle and the polymer coating.                                                             
The coating thickness h can then be calculated from equation (2.2). The radius r of a silica 
nanoparticle is 6 nm. The densities of the host particles and the polymer are ρSliica (=2.65 







Figure 2.18  TGA micrographs for uncoated SNPs and Eudragit coated SNPs after post-
treatments (filtration, sonication and drying). 
 
Using the results of TGA experiments for different amount of SNPs added, one can 
estimate the average nanocoating thickness on the SNPs from equation (2.2). For example, 
0.05 g of SNPs added to the original feed solution resulted in a thickness of 4.3 nm whereas 
0.10 g of SNPs yielded a thickness of 3.9 nm. With a further increase in SNP addition to 
0.15 g, the coating thickness decreased to 3.6 nm. The amount of SNPs plays an important 
role in polymer coating using the SHFCC method since the precipitated polymer will coat 
every SNP due to heterogeneous nucleation. The higher the amount of silica added, the 
lower the amount of polymer that will be precipitated on a given particle (resulting in a 
thinner coating) due to the much higher density of nucleation sites with increasing number 
of SNPs. All of these experiments were carried out in the larger SHFCC module. 
The coating thickness can also be determined directly by measuring the coating 
thickness from the STEM micrographs of coated SNPs based on the scale bar at the bottom 
left side of the images (see Figure 2.21 provided later). Figure 2.19 shows that the measured 

























coating thicknesses obtained from the TGA studies described above. The results from 




Figure 2.19  Results of coating thickness vs. silica addition (larger module) obtained by 
two methods: STEM and TGA. 
 
STEM micrographs shown in Figure 2.20 are 2D mapping images obtained by 
EELS in which the green cover represents the polymer coating and silica nanoparticles 
appear as red and purple zones. This figure shows that all silica nanoparticles were 
uniformly coated by Eudragit RL 100 in both the small and the large module. One does not 
observe any significant difference in coating thickness between the two modules. Figures 
2.20 (a) and 2.20 (b) show that the coating thickness in the small and large modules is 3.6 
and 4.0 nm, respectively. The very limited difference in coating thickness from one module 
to another indicates that as long as the residence time is the same, scaling up by simply 





























(a)                                                                  (b) 
Figure 2.20  EELS 2D elemental maps for coated SNPs, carbon K-edge in green, silicon 
L3,2-edge in red or purple from (a) the small module and (b) the large module. 
 
STEM analysis is a good way to characterize the film coating thickness, surface 
morphology, element distribution, particle size and degree of agglomeration. In the present 
case, a 1D line scan and 2D mapping provided by EELS add-on are used to analyze the 
samples. The blue straight line in Figure 2.21 (a) shows that the detector moves along the 
direction of arrow so that it first contacts the left side of the polymer coating boundary, 
passes through the interior of the SNP, and then across the right polymer coating boundary. 
Two peaks at the edge of the particle showing the carbon profile in Figure 2.21 (b) illustrate 
the polymer coating around the outer surface area of the nanoparticle. EELS spectrum (not 
shown here) confirmed that the nanoparticle is silica as it contains three elements, silicon, 
oxygen and carbon which comes from the coating. Figure 2.21 (c) is the silicon intensity 
profile across the particles following the same arrowed line in Figure 2.21 (a) which also 





Figure 2.21  (a) STEM images of coated nanoparticles; (b) carbon intensity profile and (c) 
silicon intensity profile along the arrowed line in (a). 
   
STEM 2D mapping (Figure 2.22) can directly visualize different element 
distributions to reveal the coating morphology. Figure 2.22 (b) shows that the polymer 
coating is evenly distributed over the entire SNP surface area and the thickness is quite 
uniform. The actual coating thickness can also be estimated by using the scale bar on the 
bottom left of Figure 2.22 (a). In this case the thickness is estimated to be 4 nm.  
 
 
Figure 2.22  EELS 2D elemental map of (a) carbon K-edge, (b) silicon L3,2–edge and (c) 





Whether the SHFCC technique can be employed to coat host nanoparticles having 
different surface properties such as hydrophilicity or hydrophobicity has also been 
investigated. For all of the results presented above, Aerosil 200 which is hydrophilic was 
used as the host particles. However, Aerosil R974, a hydrophobic silica particle having a 
primary particle size of 12 nm, was also successfully coated with Eudragit RL100 by 
applying the SHFCC technique (see Figure 2.23). The green area in this figure suggests 
that the polymer was evenly coated on the silica (red area) particle regardless of whether 
the particle surface is hydrophobic or hydrophilic. The thickness of the coating appears to 
be almost the same in both cases. This suggests that the SHFCC-based polymer coating 
technique can be broadly utilized to coat nanoparticles having different surface properties. 
 
 
                                        (a)                                                         (b) 
Figure 2.23  EELS 2D elemental maps (carbon K-edge in green, silicon L3,2–edge in red) 
of (a) Aerosil R974 and (b) Aerosil 200. 
 
The images in Figure 2.23 also show that about 2 to 5 SNPs tend to stick to one 
another forming agglomerates due to the strong van der Waals forces between the 
nanoparticles. Another reason for agglomeration is that during polymer coating, 
precipitated polymer will not only cover the host particle, but also interconnect the coated 




tendency for agglomeration by SNPs, an additional particle coating experiment was done 
by increasing the surfactant concentration and immediately applying sonication to break 
the soft bonding between the coated SNPs. In these experiments, the concentration of SDS 
was doubled from 0.0035M to 0.007M. After the coated products were collected on a filter 
paper, a certain amount of coated particles was immediately put in a small bottle containing 
water and sonicated for 1 minute. It was then dropped into the cuvette and analyzed in the 
Beckman Coulter N4 PLUS.  
The mean particle size, the number of agglomerated SNPs and the PSD were 
determined for three samples: the uncoated SNPs; coated SNPs produced by the lower 
surfactant concentration (0.0035M); SNPs produced by higher surfactant concentration 
(0.007M) and the procedure just described above. Figure 2.24 illustrates the particle size 
distribution (PSD) of the three samples. It is clear that increasing the concentration of the 
surfactant and reducing any delay in further processing by undertaking sonication 
immediately reduces the extent of aggregation substantially. The inset on top of the figure 
identifies the mean size of the particles and the estimated aggregation or agglomeration of 
the nanoparticles based on the primary particle size of a single SNP (12 nm). Before coating 
it appears that on an average about four primary nanoparticles are sintered together and 
aggregated with an estimated size of 50 nm. After coating with Eudragit in the presence of 
a higher surfactant concentration based on the measured mean size (103 nm), about nine 







Figure 2.24  Particle size distribution by number for uncoated and coated SNPs by two 
methods; mean particle size and the extent of agglomeration of the particles are provided 
for the three cases in the inset at the top of the figure. 
 
 
It is important to note that since the silica nanoparticles were produced in a high 
temperature furnace, sintering of the primary SNPs as well as attractive van der Waals force 
caused uncoated SNPs of 12 nm diameter (blue line) to show a certain level of aggregation. 
The PSD of the coated nanoparticles by the standard procedure using a lower level of 
surfactant is much wider than that of the uncoated particles due to the fact that polymer 
coating will also cause the particles to stick to one another and form solid bridges between 
particles upon drying even in the presence of a surfactant and sonication post treatment. 
This was also observed in the EELS images of Figure 2.23. However higher surfactant 
concentration and reducing post-treatment processing delays considerably reduced the 
level of observed agglomeration.  




diffuse throughout the extracellular space in rat and human brains which is especially 
useful for diseases in the case of a compromised blood-brain barrier. However, recent 
literature evidence suggests that monodisperse NPs of size less than 50-60 nm exhibit 
superior drug delivery performance[39 . Surface functionalization of mesoporous SNPs 
with polyethylene glycol-polyethylenimine copolymers enhanced delivery of drugs loaded 
in 50 nm mesoporous SNPs[40 . Therefore it would be ideal to coat NPs which do not 
show any level of agglomeration or aggregation. In the present research, the Evonik fumed 
silica NP used is already aggregated to start with as a result of their manufacturing process. 
Use of host NPs and or drug nanoparticles which do not show any initial aggregation should 
lead to reduced agglomeration in coated NPs. 
Coating of silica nanoparticles with a polymer by the solid hollow fiber cooling 
crystallization technique was investigated here. Both hydrophilic and hydrophobic SNPs 
having a primary size of 12 nm were successfully coated with Eudragit RL100 in two 
different SHFCC modules to demonstrate that scale-up can be relatively easy to achieve 
without affecting the quality/thickness of the coating. The only difference between the two 
modules is the number of hollow fibers. Different characterization techniques were 
employed to demonstrate that the polymer coating on the host SNPs was relatively uniform 
and the thickness of the coating can be tailored by varying the operating parameters. This 
technique was also successfully applied to coat submicron particles as shown in Section 
2.3. Additional experiments focusing on polymer coating of drug particles will be 







CONTINUOUS SYNTHESIS OF POLYMER COATED DRUG CRYSTALS BY 




To achieve the needed therapeutic effects in a host via controlled drug delivery, two 
methods are usually employed: dispersion of the drug in a polymer matrix which may 
degrade or swell with time or encapsulation of individual drug particles or crystals inside 
a polymeric coating. A polymeric coating of a drug particle or crystal is additionally useful 
when a fragile drug has to be protected from an adverse environment such as a highly acidic 
condition. This part of the thesis is focused on developing a polymeric coating on drug 
crystals by the novel SHFCC process which can be used for drug delivery systems and 
other potential applications [41][42]. 
Figure 3.1 (a) depicts a single polymeric solid hollow fiber. It can serve as a heat 
exchanger where the feed solution flowing in the tube side can be cooled down by the cold 
liquid circulating on the shell side. The hollow fiber was made of polypropylene (PP) which 
has a great deal of pH, chemical and solvent resistance. This nonporous fiber wall has a 
relatively smooth surface to minimize the possibility of clogging problem inside of the 
hollow fiber. Figure 3.2 (b) illustrates a solid hollow fiber cooling crystallizer (SHFCC) 
module that consists of a number of hollow fibers in the shell. The number of hollow fibers 





(a)                                                       (b) 
Figure 3.1  (a) Single solid hollow fiber heat exchanger; (b) Solid hollow fiber membrane 
based cooling crystallizer module. 
 
3.2 Materials and Methods 
3.2.1  Materials 
Eudragit RL 100 (Mw, 150,000; a copolymer of methyl methacrylate, ethyl acrylate and 
methacrylic acid ester) was purchased from Evonik-Degussa (Parsippany, NJ). Drug 
particles Griseofulvin (GF) obtaining from Letco (Decatur, AL) was used as host materials 
(mean particle size < 10 µm, partially dissolved in acetone, practically insoluble in water) 
without further treatment. Sodium dodecyl sulfate (SDS) as a surfactant was also obtained 
from Sigma-Aldrich (St. Louis, MO).  
 
3.2.2  Experimental Methods 
Cloud point measurement was undertaken for the cooling experiments. Cloud point value 
of 15 oC was selected and the volume ratio of acetone/water used was 2.5/0.5. Detailed 
procedure was mentioned in Section 2.2.3. 
A schematic diagram of the coating setup is the same as in Figure 2.1. An amount 
of 2.4 g of Eudragit RL100 granules was first placed into a flask containing 20 ml acetone 
solution and kept under stirring for about 30 min in order to fully dissolve the polymer. 




Most of the drug particles were fully dissolved into the solution; there were some left-over 
drug crystals still suspended in the solution. Next 4 ml of DI water and 0.025 g of SDS as 
surfactant were added into the flask. After 30 min stirring, the flask containing the well-
mixed solution was placed in a water bath at a constant temperature.  
When the experiment was started, first an aqueous solution of 50 % by volume of 
ethylene glycol was circulated through the shell side; a chiller (Polystat CR250WS, Cole-
Parmer, Vernon Hills, IL) cooled the glycol solution to -9 oC in the shell side. After about 
2 min when the tube side wall was fully cooled down by the shell side cold liquid, the 
solution was fed into the lumen side of the SHFCC by a pump (Masterflex, model no.7523-
20, Cole-Parmer, Vernon Hills, IL) at a rate of 3.5 ml/min. The temperature indicated by 
thermocouple T1 was 45 oC, the feed side polymer solution containing the drug was cooled 
down in the lumen side of the module from 45  oC to 5  oC (unless otherwise mentioned) by 
the cold liquid from the shell side. Polymer was crystallized from the solution and 
subsequently coated the drug particles due to the rapid temperature reduction. Coated drug 
crystals along with the excess polymer solution were swept out of the outlet of the SHFCC 
unit by the incoming feed solution since the SHFCC process is continuously operated. A 
vacuum microfiltration system (Omnipore Membrane, PTFE, 0.45 µm pore size, 90 mm 
filter diameter, Millipore, Billerica, MA) underneath the outlet was used to remove most 
of the solution at a pressure of 15 psig; the cake on the filter paper containing the coated 
particles was collected for post-treatment and characterization. 
 
3.2.3  Characterization of Coated Griseofulvin Drug Crystals 
The X-Ray Diffractometer by Empyrean (Philips, Westborough, MA) was used to measure 




operating voltage and amperage of 45 kV and 40 mA, respectively. Sample powder was 
evenly dispersed on a sample holder and the surface was gently swept by a glass to maintain 
co-planarity in the area in order to get the accurate single source. The range of scanning 
was adjusted from 5 o to 45 o 2θ at a step size of 0.02 o 2θ and 15 o time per step under the 
scanning of 255 detecting channels. 
Dissolution test was run to compare the difference between uncoated and coated 
GF drug particles via a Distek Dissolution tester (North Brunswick, NJ). 0.27 % of SDS 
solution in 900 mL volume was prepared as a buffer solution for the test according to the 
USP II paddle method. Medium temperature was maintained at 37 oC. An amount 
equivalent to a dose of 50 mg of Griseofulvin sample was dropped into a dissolution vessel 
containing buffer solution while a 50 rpm of the paddle stirring speed was maintained. 
After 1, 3, 5, 10, 20, 30, 40, 50 and 80 min, a syringe was used to extract the solution with 
a volume of 6 ml and immediately analyzed by UV spectroscopy (52100 UV+, Cole-
Parmer, Vernon Hills, Illinois) at a wavelength of 296 nm. The transmissivity of 0.27 % 
SDS buffer solution was first analyzed as the benchmark before the test. 
A differential scanning calorimetry (DSC 7, Perkin Elmer, Waltham, MA) was 
applied to determine if the melting peaks in the DSC thermogram are the same before and 
after the coating of drug particles. About 3 mg of the sample was heated over a temperature 
range of 30-250 oC at a rate of 10 oC/min, the melting point was detected by Pyris software. 
A Raman Microscope (DXR, Thermo scientific, Waltham, MA) was used for 
identifying the molecular structures for uncoated/coated drug crystals. Laser wavelength 
was set at 780 nm while the Laser power was 10 mw for the run. 




applied to measure the particle size distribution. An aqueous sample containing the 
suspension of uncoated/coated drug particles was first under sonication for 30s before the 
testing in order to break the soft bonding among coated particles.   
SEM, TGA instruments were already mentioned in Section 2.2.4 
 
3.3 Results and Discussion 
 
3.3.1  Crystallization of Griseofulvin Drug Particles in SHFCC Unit 
A small amount of dry GF powders as received was put on a stub pin mount and 
characterized by SEM without any treatment. Figure 3.2 illustrates micrographs of pure 
GF particles under different magnifications. It illustrates the drug particles as received have 
very rough surfaces and irregular shapes with a diameter around 10 micrometer. 
   
(a)                                                                    (b) 
Figure 3.2  SEM micrograph of (a) pure drug powders as-received and (b) drug powders 
after precipitation in a SHFCC unit without any polymer. 
 
In order to identify whether SHFCC process will affect the characteristic of drug 
particles, the as-received GF particles were analyzed by SEM after the SHFCC process 
without the presence of any polymer. GF particles were first fully dissolved into solution 




after about 30 min mixing when there were no drug particles suspended in the solution, the 
solution was passed through the tube side of the SHFCC device while the cold liquid was 
circulating in the shell side; drug particles were collected at the outlet in the other end by a 
filter paper and subjected to characterization.  
Figure 3.2 (b) is the micrograph of pure GF particles after pumping through SHFCC 
device without the addition of Eudragit RL 100. Compared to Figure 3.2 (a) in which the 
drug shows no crystalline shape, drug particles in Figure 3.3 (b) have grown up to be well-
defined crystals after SHFCC process. The surface is relatively smooth with only some tiny 
crystals attached to it. That is because the drug was first fully dissolved in the acetone 
solution (0.55 g GF in 20 mL acetone) in the flask; after passing through the SHFCC heat 
exchanger, GF particles precipitated out from the solution due to rapid temperature 
reduction in the SHFCC module.   
 
3.3.2  Coating of Griseofulvin Drug Particles with Eudragit Polymer in SHFCC unit 
First, the polymer has to be dissolved in the acetone solution prior to the drug particles in 
order to provide the coating material for Griseofulvin. The fully dissolved polymer solution 
in acetone with small amounts of drug particles suspended (most of the drug particles were 
fully dissolved in the solution) was pumped through SHFCC cooling crystallizer, the drug 
will crystallize first, polymer will precipitate later and cover the drug particles. In Figure 
3.3, a thin polymer coating can be seen on each drug crystal. Compared to Figure 3.2 (b) 
in which the drug particles were crystallized without the presence of any polymer, the 
surface morphology around the drug crystals also appears to be different which implied the 






Figure 3.3  SEM micrographs of polymer coated drug particles after precipitation. 
 
3.3.3  TGA Characterization of Polymer Coated Drug Particles 
TGA is a precise thermal analysis method to identify percent weight loss of sample as a 
function of increasing temperature. It can be used in the case of polymer coated drug 
particles to measure the weight of polymer coating if one can identify the temperature range 
of weight loss caused by drug decomposition and polymer decomposition since drug 
particles and polymer will both decompose to cause weight reduction of the TGA 
thermograms when heating up.  
The polymer decomposition range can be identified by the TGA graph of previous 
experimental results of coating silica particles by polymer. In the case of silica particles 
coated by the polymer Eudragit RL 100, since the silica (host particles) will not decompose 
during the heating up process, weight loss is almost completely contributed by polymer 
decomposition. Figure 3.4 (a) shows that the primary range of polymer decomposition is 
from 270 to 400 oC. Figure 3.4 (b) shows the TGA results for the uncoated/coated drug 
particles by SHFCC method in which the blue curve illustrates the results for the uncoated 
GF while the red dash curve shows the TGA results for polymer coated GF particles. The 




on this information, the actual polymer weight loss (mpolymer) can be estimated to be 13 % 
(The Y-axis value difference from the range of 270 to 400 oC) from the dashed curve in 






Figure 3.4  TGA results of (a) polymer coated silica particles; (b) as-received GF and 












































Every drug particle is assumed before coating to be a perfect rectangular 
parallelepiped with three dimensions of Hdrug, Wdrug and Ldrug; the polymer coating 
thickness h is covering the entire drug particle. The thickness of the polymer coating on 
GF particles can be estimated by equation (3.1)  
[( 2 ) ( 2 ) ( 2 ) ]
drug drug drug drug
polymer dr
drug
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         (3.1) 
Here the ratio mdrug/mpolymer = 87 %/13 %= 6.7 was determined by the weight loss 
of drug and polymer from Figure 3.4 (b). The densities of the drug particles and polymer 
are ρdrug (=1.4 g/ml) and ρpolymer (=1.1 g/ml), respectively. The height, width and length can 
be estimated from Figure 3.2 (b) to be 17 μm, 6 μm and 8 μm, respectively. The polymer 
coating thickness was estimated to be 0.26 μm by using equation (3.1). 
 
3.3.4  XRD and Raman Spectroscopy  
XRD analysis was first performed to identify the crystal structure of the sample. Figure 3.5 
(a) shows the XRD results for uncoated and coated GF particles. As can be seen from the 
graph, there was no alteration in every peak position which implied that the polymer 
coating of drug particles did not damage the crystal structure of Griseofulvin since the 
characteristic peaks of the two samples are identical. Figure 3.5 (b) describes the Raman 
spectra for the uncoated/coated drug crystals at the shift range from 0 to 3500 cm-1.In 
accordance with the XRD results, the characteristic peaks for both uncoated GF and coated 
GF particles are all the same. This suggests that coating of the drug particles by the 
precipitation of the polymer from the solution by SHFCC process did not alter the drug 
molecular structure; therefore the drug can retain its pharmaceutical effect even after the 








Figure 3.5  (a) X-ray diffractograms of uncoated GF and coated GF samples; (b). Raman 
spectra for uncoated GF and coated GF samples. 
 
3.3.5  Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry analysis was performed for the as-received GF and the 
Eudragit coated GF particles as shown in Figure 3.6. The peak position determined by the 




identical to the peak value of 221.37 oC for the polymer coated GF. The slight intensity 
difference may be due to the polymer coating covering the entire drug particles that prevent 




Figure 3.6  Differential scanning calorimetry patterns for uncoated GF and coated GF. 
 
3.3.6  Dissolution Testing Study  
To identify the effect of controlled release of drug when GF was coated by the polymer 
using solid hollow fiber membrane-based cooling crystallization method, the dissolution 
study of the as-received drug, uncoated drug and the polymer coated drug were carried out. 
The dissolution test results are shown in Figure 3.7. The dissolution profiles for as-received 
GF and uncoated GF are very similar which indicated that even when the GF particles was 
re-precipitated from the solution by SHFCC device with different crystal shapes, it did not 
prevent or change the estimate of the time for the drug to be 100 % dissolved in the buffer 
solution. The dissolution profile of the coated GF particles (green curve) is completely 




min which implied that the polymer coating was acting as a barrier to prevent the drug 




Figure 3.7  Dissolution profiles for crystals of as-received GF, uncoated GF, and polymer 
coated GF, the latter two obtained by the SHFCC technique. 
 
3.3.7  Crystal Size Distribution Measurement  
The crystal size distributions (CSD) of the as-received uncoated drug particles as well as 
Eudragit RL 100 coated Griseofulvin drug particles collected from the SHFCC process 
were measured by LS 230 laser diffraction analyzer to compare of the level of 
agglomeration before and after coating. Figure 3.8 illustrates the CSD profiles of the 
uncoated and coated drug crystals in which the median size of the as-received GF (11.6 
μm) was about 3 times smaller than that of the polymer encapsulated GF (31.19 μm). One 
possible reason is due to the high level of polymer connectivity over the coated GF crystals 
that led to a certain amount of agglomeration since the precipitated polymer will form 


























Figure 3.8  Crystal size distribution of as-received and coated Griseofulvin drug particles.  
 
A novel approach for continuous synthesis of polymer coated of Griseofulvin drug 
particles has been developed by using the solid hollow fiber cooling crystallizer. Following 
the previous determination of the cloud point for Eudragit RL 100/acetone/water solution 
by an UV spectrophotometer, the cloud point temperature of the ternary system was set to 
be 15 oC. Drug particles were evenly coated by the polymer precipitated from the acetone 
solution inside of the SHFCC module. Further tests using XRD, Raman and DSC indicated 
that the polymer coating covering the drug particles will not influence the pharmaceutical 
effects of the drug. The dissolution test results suggest that the coated drug demonstrated a 
controlled release potential for drug delivery system since the coated drug has a much 
slower dissolution rate with time compared to the uncoated drug. 
This novel method for coating of drug particles should be attractive for the 
pharmaceutical industry especially in the area of drug delivery. The relatively simple set 
up and the modest requirements for experimental conditions provide an economic 




be contrasted with most of coating techniques also suggests a possibility of mass 
production. Next chapter will introduce another novel coating technique – PHFAC, to coat 

























CONTINUOUS POLYMER COATING/ ENCAPSULATION OF SUBMICRON 




Conventional crystallization/precipitation processes for coating particles with a polymer 
from its solutions rely on either cooling or solvent evaporation or anti-solvent methods or 
chemical reactions. Of these methods, anti-solvent techniques continue to be of 
considerable interest. Even though impinging-jet mixers are being utilized to this end in 
preference to standard crystallization devices, they are plagued by many shortcomings. 
Another novel technique is proposed here for continuous polymer coating of 
crystals/particles by adapting the porous hollow fiber anti-solvent crystallization (PHFAC) 
technique besides the SHFCC process which was already introduced in Chapter 2. This 
technique is facile and easily scalable and can be used for a variety of polymers and 
solvents. How submicron (550 nm) and nanoparticles (12 nm) of silica can be coated 
continuously with thin layers of the polymers Eudragit RL 100 and PLGA is illustrated 
here. 
 
4.1.1  Porous Hollow Fiber Anti-solvent Crystallizer/Precipitator 
Two potential configurations of a single porous hollow fiber anti-solvent crystallizer 
(PHFAC) are shown in Figure 4.1. The porous hydrophilic hollow fiber was made of the 
polymer Nylon 6; it has an excellent resistance to pH and a variety of organic solvents. 
This fiber has an inner diameter (ID) of 600 µm and an outer diameter (OD) of 1000 µm. 




few pores having the largest size. Anti-solvent crystallization using the hollow fiber-base 
membrane may be carried out in two ways shown in Figures 4.1 (a) and 4.1 (b). In both of 
these configurations, the anti-solvent is made to permeate through the pores. Alternate 
configurations wherein the feed suspension is made to permeate through the pores are not 
possible for the particular hollow fiber selected since in the case of submicron particles the 
diameter of the host silica particles used (0.55 µm) is larger than most of the pores. Some 
agglomeration of the silica particles can occur in the feed suspension leading to clogging 
of the pore mouths. 
      Figure 4.1 (a) illustrates the scheme wherein polymer crystallization/precipitation takes 
place in the tube side. The anti-solvent permeates through the pores from the shell side into 
the tube side while the feed polymer solution-suspension of silica particles flows in the 
tube side. Injection of the anti-solvent through numerous pores generates intense mixing 
between the two liquids leading to precipitation of the polymer and covering of the host 
silica particles present in the feed solution-suspension in the tube side. 
      Figure 4.1 (b) illustrates a reversed configuration. The feed solution-suspension was 
pumped through the shell side; the anti-solvent was pumped through the tube side such that 
it permeated into the shell side as numerous jets streaming into the polymer solution-
suspension. This led to rapid precipitation/crystallization of the polymer in the shell side 
and coating of the silica particles in the suspension. This particular configuration is 
preferred over that shown in Figure 4.1 (a). Due to the larger cross-sectional area in the 
shell side, silica particles are more easily swept away compared to that in the tube side 




the average inter-fiber spacing on the shell side. All experiments were done using the 
configuration shown in Figure 4.1 (b).     
 
 
(a)                                                           (b)                                
Figure 4.1 Porous hollow fiber anti-solvent crystallization (PHFAC) -- operating approach 
for the permeation of anti-solvent through the pores: (a) crystallization in the tube side; (b) 
crystallization in the shell side. 
 
 
Figure 4.2  Schematic of porous hollow fiber anti-solvent crystallizer (PHFAC). 
 
Figure 4.2 is the photo of a typical porous hollow fiber-based anti-solvent 
crystallizer (PHFAC). It contains 23 porous nylon hollow fibers inside the shell made of 
fluorinated ethylene propylene (FEP). The shell internal diameter is 8 mm and the effective 
length is 8 cm. The two ends of the hollow fibers at the end of the shell side tube were 




resin (C4 and D, Armstrong, Easton, MA). As shown in Figure 4.2, water, the anti-solvent, 
was passed through the lumen of the hollow fibers in the tube side while the polymer 
solution containing a suspension of silica particles was pumped in the shell side of the 
module co-currently. 
 
4.2. Materials and Methods 
4.2.1  Materials 
The host submicron silica particles, Cosmo 55 (550 nm nonporous hydrophilic spherical 
particles), were obtained from Presperse (Somerset, NJ). Silica nanoparticles used were 
Aerosil 200 (non-porous hydrophilic fumed silica with a diameter of 12 nm) (Evonik-
Degussa, Parsippany. NJ). Coating polymers were: Eudragit RL 100 (Mw, 150,000; a 
copolymer of methyl methacrylate, ethyl acrylate and methacrylic acid ester) from Evonik-
Degussa (Parsippany, NJ); PLGA (Poly (D, L-lactide-co-glycolide), Mw, 7,000-17,000) 
from Sigma-Aldrich (St. Louis, MO). Acetone, a good solvent for Eudragit RL 100, 
dioxane, a good solvent for PLGA, and the surfactant sodium dodecyl sulfate (SDS) were 
obtained also from Sigma-Aldrich. Deionized water was used as the anti-solvent. 
 
4.2.2  Experimental Methods 
Feed solution-suspension was prepared in a flask by first introducing 2.4 g of Eudragit RL 
100 (or PLGA) in 20 ml acetone (or dioxane) solution. After about 30 min when the 
polymer was fully dissolved, 4 ml of water was added in the solution to slightly decrease 
the solubility of the polymer. This was done to make the polymer solution more sensitive 
to the anti-solvent as will be seen later. Next 0.4 g of Cosmo 55 silica particles was added 




during the experiment.  
Figure 4.3 illustrates the process schematic used for the PHFAC-based coating of 
the silica particles. A peristaltic pump (Masterflex L/S model 7518-60, Cole-Parmer, 
Vernon Hills, IL) was used first to pass DI water to the tube side of the module. Since the 
other end of the module tube-side was blocked by a valve, tube side pressure increased 
from 0 to 15 psig so that the water permeated through the pores in the hollow fiber wall to 
the shell side. The feed solution-suspension was introduced into the shell side of the 
PHFAC unit by another identical pump after 2 min.  
The order of pumping the liquids should not be reversed. If the feed solution is first 
passed to the shell side, then part of this solution would have permeated to the lumen side; 
that would have led to subsequent mixing of the anti-solvent with the polymer solution and 
the precipitated polymer would have stayed in the tube and eventually would have led to 
clogging of the tube side. The reading on the pressure gauge 2 ( Figure 4.3) was close to 
zero psig since the volume of the shell side is relatively large offering the solution almost 
no resistance to pass through. Innumerable water streams from the pores were injected into 
the feed polymer solution-suspension in the shell side generating strong mixing of the 
solutions. The solubility of the polymer drastically deceased because of the introduction of 
the anti-solvent so that polymer precipitated and covered the silica host particles. The 
coated product along with the excess polymer solution and water were continuously 
pumped out through the shell side outlet. A microfiltration device was placed under the 
outlet to collect the particles on a filter paper (Omnipore Membrane JHWP09025, PTFE, 
hydrophilic, 0.45 μm, 90 mm; Millipore, Billerica, MA). The coated silica particles were 




The flow rate on the hollow fiber lumen side was kept at 11 ml/min and the shell 
side flow rate was maintained at 6 ml/min. It is important to maintain a reasonable flow 
rate in the shell side. First, a polymer such as PLGA is highly sensitive to the anti-solvent; 
the presence of just a little anti-solvent in the shell side will lead to extensive precipitation 
of the PLGA. Unless the shell-side flow rate is high enough to flush out the precipitates 
once they are formed, the precipitates can block the shell side. Secondly, the shell side flow 
rate is related to the pressure in the tube side. The shell side flow rate has to be held at a 
certain level to increase the pressure difference between the tube side and the shell side so 
that the anti-solvent water can successfully permeate from the tube side to the shell side 
and achieve intense mixing with the feed solution-suspension. One can generate a high 
super-saturation level if a high water flow rate is created so that a maximum amount of the 











Figure 4.3  Experimental setup for continuous polymer coating of silica particles in a 









4.3. Results and Discussion 
4.3.1  Coating of Submicron Silica Particles with Eudragit RL 100 
Submicron silica particles (Cosmo 55, 550 μm) were first coated with the polymer Eudragit 
RL 100. The polymer was precipitated in the PHFAC module due to the rapid solubility 
reduction when DI water was introduced from the tube side thus coating the silica host 
particles. Eudragit RL 100 is not as sensitive to the anti-solvent water compared to PLGA. 
Even when a considerable amount of water was quickly introduced into a solution of 
Eudragit, limited precipitation happened; the color of the solution changed from clear to 
slightly cloudy per visual inspection. Therefore, a high concentration of polymer (10 wt%) 
as well as a high water permeation rate from the tube side has to be maintained to ensure 
sufficient polymer precipitation on the silica particles.  
It appears that the quantity of the host silica particles plays an important role in 
determining the coating thickness since the polymer concentration of the solution was fixed. 
Other conditions remaining fixed, the magnitude of the residence time of the feed solution-
suspension in the shell side essentially determines the amount of the polymer that will 
precipitate. Therefore, the higher the number of host particles present in the solution, the 
lower will be the amount of polymer that will precipitate on each silica particle and coat it. 
To that end, three identical Eudragit solutions were prepared containing exactly the same 
amount of water, acetone, polymer and SDS; the only difference between these solution-
suspensions was the amount of silica added (0.2 g, 0.4 g and 0.8 g).  
Thermogravimetric analysis (TGA) was used to analyze the weight loss of the 
polymer coated silica particles. The polymer coating that covered the silica particles started 




illustrates the TGA results for coated Cosmo 55 particles for three different amounts of 
silica in the feed solution-suspension and the uncoated Cosmo 55 particles as received. The 
as received silica sample lost less than 1% of its weight after heating (the solid line in 
Figure 4.4). This suggests that the weight loss of the coated silica samples was essentially 
due to polymer loss. According to the TGA results, the % weight loss decreased when more 
silica was added to the solution implying a thinner coating on the silica particles. The % 
weight losses for the cases of 0.4 g silica and 0.2 g silica addition are relatively close 
implying that the amount of polymer that can be deposited on the silica particles has an 
upper limit. Most of the experiments were therefore run with 0.4 g as the mass of silica. A 
lesser amount of silica addition will lead to a somewhat thicker coating and potentially 
increase the agglomeration of the polymer coated particles. Too many silica particles may 




Figure 4.4  TGA micrographs of the as-received silica (Cosmo 55) as well as Eudragit RL 



























Since the as-received Cosmo 55 particles are almost perfectly spherical with a very 
narrow particle size distribution, one can assume that these silica particles are spheres of 
diameter 2r. The relationship between the mass of silica and the polymer mass has been 
expressed in Equation (2.1). The polymer coating thickness h can then be calculated from 
this equation to be 36.9 nm.  
 
 4.3.2  Characterization by Scanning Electron Microscopy 
After about 20 min of operation, a sample was obtained on the filter paper for 
characterization. SEM was used to detect the actual surface coating topography and 
composition of the polymer coated Cosmo 55 particles. Figure 4.5 shows the SEM 
micrographs of coated and uncoated dry silica particles. Compared to Figure 4.5 (a), Figure 
4.5 (b) clearly shows that the polymer was coated on every silica sphere due to 
heterogeneous nucleation. Limited amounts of polymer bridges between neighboring silica 
particles suggest soft bonding or agglomeration between particles, which can be separated 
by the external forces experienced in an ultrasonicator to obtain free-flowing coated 
particles.  
Surface elemental analysis by EDS can provide additional information of the 
composition of the coating on the silica particles. The EDS results of the uncoated and the 
coated Cosmo 55 samples are shown in Figures 4.6 (a) and 4.6 (b), respectively. No carbon 
peak appears in Figure 4.6 (a) suggesting that there was no carbon element on the as-
received silica particles. On the contrary, a clear carbon peak shown in Figure 4.6 (b) 
indicates that Eudragit RL100 polymer successfully coated the Cosmo 55 silica particles 
since only the polymer contains the element carbon. The EDS results are in accordance 





(a)                                                                  (b) 
Figure 4.5  SEM micrographs of (a) uncoated and (b) Eudragit coated silica (Cosmo 55) 







Figure 4.6  EDS results of (a) uncoated and (b) Eudragit RL 100 coated submicron silica 






4.3.3  Characterization by Scanning Transmission Electron Microscopy 
Scanning transmission electron microscopy is another tool that can be used to determine 
the coating thickness of the polymer around the silica particles. Compared to SEM, it can 
display the coating morphology more precisely. The micrograph in Figure 4.7 (a) shows 
parts of two uncoated silica particles while that in Figure 4.7 (b) shows sections of two 
Eudragit coated silica particles. The two dark partial spheres in Figure 4.7 (b) represent 
two silica particles: the polymer coating covering the particles is shown in grey. The two 
silica particles in Figure 4.7 (b) are seen to be interconnected by a polymer bridge; a thin 
polymer coating is seen around the periphery of the particles. Based on the scale bar in the 
micrograph, the thickness of the coating on a single submicron silica particle is estimated 
to be between 10 nm and 20 nm. 
 
(a)                                                      (b) 
Figure 4.7  STEM micrographs of (a) uncoated silica particles and (b) polymer coated 








4.3.4 Coating of Cosmo 55 Silica Particles with PLGA  
PLGA is frequently used as a coating material in the pharmaceutical industry since it is a 
biodegradable and biocompatible copolymer approved by FDA. Compared to a solution of 
Eudragit RL 100 in acetone, a solution of PLGA in dioxane is much more sensitive to the 
addition of an anti-solvent such as water into the polymer solution than a solution of 
Eudragit RL 100 in acetone. High levels of precipitation will take place in the shell side if 
10 wt% PLGA was added into solution. The PLGA concentration level can be a 
determining factor in the coating of submicron particles. Solutions having different 
concentrations of PLGA were therefore prepared to explore how the amount of PLGA will 
affect the coating since PLGA is much more sensitive to the anti-solvent compared with 
Eudragit RL 100.  
Figure 4.8 illustrates the results from TGA of the as received (uncoated) silica 
particles and PLGA-coated silica particles. As the solution PLGA concentration was 
increased, the amount of the precipitated polymer increased drastically, indicating that the 
extent of supersaturation of PLGA increased with the anti-solvent addition very rapidly 
and the precipitation kinetics was very fast. From the results of TGA, the percentage weight 
loss of the polymer were estimated to be 90%, 60% and 37% corresponding to PLGA 
concentrations in the solutions of 10%, 7.5% and 2.5% respectively. These extraordinarily 
high amounts of precipitation demonstrate the sensitivity of the dioxane solutions of PLGA 
used in this study to the addition of the anti-solvent water. Unlike coating with Eudragit 
RL 100, when the PLGA solution was mixed with the anti-solvent jet streams in the 




Figures 4.9 (a) and 4.9 (b) show the SEM micrographs for polymer-coated silica 
particles from 10% and 2.5% PLGA solutions respectively. In Figure 4.9 (a), silica particles 
appear to be immersed in a huge amount of PLGA precipitate. However, for 2.5% PLGA 
solution, Figure 4.9 (b) shows that the silica particles had a thick coating and were 
somewhat inter-connected but not embedded in the polymer matrix. This suggests that 
reduction of the solution concentration of PLGA can effectively decrease the coating 
thickness as well as the extent of agglomeration. Calculations using equation (2.1) suggest 
the thickness of the coating for 2.5 wt% PLGA solution to be 94 nm. Since there were some 
polymer bridges between the particles, the real coating thickness along the particle 




Figure 4.8  TGA micrographs of the as-received silica (Cosmo 55) as well as PLGA coated 
silica particles (0.4 g silica, 20 ml dioxane and 4 ml water) for different feed solution 




























(a)                                                              (b) 
Figure 4.9  SEM micrographs of PLGA coated particles from solutions containing two 
different levels of PLGA: (a) 10 wt% (b) 2.5 wt%. 
 
Could one reduce the solution concentration of PLGA further to reduce the amount 
of bridging and the coating thickness? Figure 4.10 illustrates SEM micrographs of uncoated 
silica and PLGA-coated silica for the case of a 1% PLGA solution. There is very little 
difference between the two micrographs at the level of magnification used. Compared with 
the as-received Cosmo 55, the coating in Figure 4.10(b) appears to be quite limited. The 
small amount of precipitation of PLGA was not enough to cover the particles; instead small 
amounts of polymer appear to be attached to the surface of some of the silica particles or 
lie in between particles. It appears that PLGA concentration cannot be reduced too much 
since it may result in an imperfect coating.  
Therefore, the 2.5 wt% solution of PLGA was selected for further anti-solvent 
crystallization/precipitation experiments and characterization. The EDS results of uncoated 
silica as well as 2.5 wt% PLGA solution-based coated silica particles are shown in Figure 
4.11. Compared to Figure 4.11 (a), the carbon peak in Figure 4.11(b) demonstrates the 






(a)                                                                 (b) 
Figure 4.10 SEM micrographs of uncoated and PLGA coated particles: (a) uncoated (b) 1 













4.3.5 Particle Size Distribution  
The particle size distributions of the Cosmo 55 silica particles coated by Eudragit RL 100 
or PLGA as well as the as-received silica particles were analyzed by laser diffraction to 
quantify the level of agglomeration of the particles after coating. Figure 4.12 shows the 
results for the particle size distributions of the as-received silica, Eudragit-coated silica and 
PLGA-coated silica. As expected, the mean size of Eudragit-coated silica was smaller than 
that of the PLGA coated silica as shown in Table 4.1 and Figure 4.12. It is clear that the 
high level of particle connectivity witnessed in PLGA precipitation led to a greater 
agglomeration of the coated particles.   
 
Table 4.1  Specifications of PSD Results for the As-received Silica, Eudragit Coated Silica 
and PLGA Coated Silica Particles for Cosmo 55 
 
 Mean size (μm) d10 (μm) d90 (μm) 
As received silica 0.595 0.266 0.969 
Eudragit coated silica 1.398 0.704 2.324 
PLGA coated silica 1.810 1.451 2.215 
 
 
Figure 4.12  Particle size distributions of as-received silica, Eudragit and PLGA coated 




















Silica coated with Eudragit RL




4.3.6 Comparisons of Two Different Polymer Coatings on Submicron-size  
Silica Particles 
Both the polymers, Eudragit RL 100 and PLGA, were used to successfully coat the host 
silica particles. Each polymer has its own advantages as a coating material for the PHFAC 
process. Eudragit RL 100 produces somewhat more uniform coating and lesser amount of 
polymer bridging between neighboring silica particles; the coating thickness can be 
adjusted by controlling the amount of added silica in suspension for a given residence time. 
The coating formed by Eudragit is also thinner than that of PLGA. Agglomeration was also 
reduced considerably because of the smaller amount of polymer precipitation. On the other 
hand, PLGA is a widely used coating material especially in the field of drug delivery for 
controlled release. Due to the high sensitivity of the dioxane solutions of PLGA to the anti-
solvent used, the coating thickness can also be adjusted simply by changing the 
concentration of PLGA in solution. From the results of Figure 4.4 with Eudragit, one may 
expect that the amount of silica particles added to a solution can also influence the coating 
thickness. 
 
4.3.7  Continuous Polymer Coating of Nanoparticles by PHFAC  
Coating of silica nanoparticles (Aerosil 200) by Eudragit RL 100 has also been studied 
using the novel PHFAC method but not as extensively as the coating of the submicron 
silica particles. The preliminary results are illustrated here to demonstrate that silica 
nanoparticles can be coated with the Eudragit RL 100 polymer as well. Figure 4.13 (a) 
shows a SEM micrograph of the coated silica nanoparticles. The micrograph shows that 
the silica particles were covered by the precipitated polymer although there was a 
significant level of agglomeration among the coated particles. One reason for the 




tendency to stick to each other due to the strong van der Waals forces between the 
nanoparticles. Another reason is that the precipitated sticky polymer not only covers the 
particles but also connects the particles by forming polymer bridges between the particles. 
This type of agglomeration may be minimized by adding increased amounts of surfactants 
and applying sonication to break the soft bonding of the coated nanoparticles. Figure 4.13 
(b) shows EDS results for the coated nanoparticles in which the carbon profile 




(a)                                                                (b) 
Figure 4.13  (a) SEM micrograph and (b) EDS results of polymer coated silica 
nanoparticles using the PHFAC process. 
 
For the silica nanoparticles, TGA results are shown in Figure 4.14. The dashed blue 
line represents the weight loss profile of the as-received silica nanoparticles as the 
temperature was increased to 550 oC. As expected, there was negligible weight loss since 
silica nanoparticles do not decompose during the heating. However, the polymer-coated 
silica nanoparticles shown by the red curve lost about 70% of the weight since the polymer 
decomposed during the heating. The coating thickness on the nanoparticles can be 






Figure 4.14  TGA micrographs of as-received silica as well as Eudragit RL coated silica 
nanoparticles (Aerosil 200). 
 
The technique of porous hollow fiber anti-solvent crystallization (PHFAC) was 
successfully adapted to continuously coat submicron (550 nm) and nanoparticles (12 nm) 
of silica with a polymer. After vacuum drying and sonication, free-flowing polymer-coated 
silica particles were obtained by this continuous process. By varying a number of 
conditions such as the silica loading in the solution-suspension and the solution 
concentration of the polymer, one can adjust the polymer coating thickness over certain 
ranges. Both the polymers, Eudragit RL 100 and PLGA, were successfully used to coat the 
silica particles using this novel method. Chapter 5 will focus on the continuous synthesis 




























CONTINUOUS SYNTHESIS OF COATED DRUG CRYSTALS BY A POROUS 
HOLLOW FIBER ANTI-SOLVENT CRYSTALLIZATION METHOD 
 
5.1 Introduction 
In controlled drug delivery systems, well-characterized and reproducible dosage forms are 
utilized to ensure that the rate and duration of drug delivery achieves the required 
concentration at the target site to provide optimum therapeutic effects. The subject of the 
controlled drug delivery by encapsulating individual drug particle in a polymeric coating 
is of interest here.  
The size range of drug particles can vary between micron-sized, sub-micron (100-
1000 nm) and nanoparticles (10-100 nm). Due to their greater solubility, high stability, 
high carrier capacity, incorporation of biodegradable and hydrophobic/hydrophilic 
substances and administration by a variety of delivery vehicles, nanoparticle-based systems 
have attracted considerable attention in the application of drug delivery [43-48]. However, 
the focus of this chapter will be micron-sized drug crystals. 
A porous hollow fiber membrane-based anti-solvent crystallization (PHFAC) 
technique was used to develop a continuous technique whereby micron-size drug particles 
having a thin polymeric coating are produced continuously from an acetone solution of the 
drug as well as the polymer used to coat it. This chapter describes the results of a facile and 
continuous method of synthesizing micron-size GF drug particles having a thin polymer 
coating based on the PHFAC technique. The polymer used to coat the crystallized drug 




The Eudragit family of polymers has very useful characteristics under physiological 
conditions. They are not degraded by enzymatic attack; they do not undergo absorption in 
the digestive tract and are physiologically inert. As enteric coating agents they find wide 
use and can control the dissolution rate of drugs in the stomach and intestine, and they are 
frequently employed in the formulation of controlled release drugs. That Eudragit RL100 
can be used to successfully coat submicron particles as well as nanoparticles using the 
technique of cooling crystallization has been shown already in Chapter 2. Further, Eudragit 
has limited sensitivity to anti-solvent addition as was observed in these earlier studies. 
The nature of the porous hollow fiber will be preferentially dictated by the anti-
solvent being pushed through and the dimensions of the submicron and nanoparticles under 
consideration. The material of the hollow fiber should not swell in the solvent environment. 
Further the pore size should be lower than the smallest particles being formed to prevent 
accidental pore clogging. With water as the anti-solvent, a hydrophilic hollow fiber, e.g., 
the nylon hollow fiber used here is needed. One can also use hollow fibers of for example, 
regenerated cellulose, hydrophilized polyvinylidene fluoride, and polyethersulfone as long 
as there is sufficient solvent resistance. If porous hydrophobic hollow fibers, e.g., Celgard 
polypropylene hollow fibers, are used, prior wetting of the pores is necessary if an aqueous 
non-wetting solution is the anti-solvent. However, a hydrophobic hollow fiber will remain 
susceptible to spontaneous wetting by the organic solvent on the shell side unless 
appropriate care is taken. 
Figure 1.12 in Chapter 1 depicted a PHFAC module containing a number of porous 
hollow fibers for continuous synthesis of polymer-coated drug crystals. As shown, each 




the hollow fiber tube side at a higher pressure permeates to the shell side where the polymer 
solution containing the dissolved drug molecules is flowing. Zarkadas and Sirkar (2006) 
[24  have demonstrated that the mixing efficiency of this process for the two liquids, the 
shell-side flowing liquid and the liquid injected from the tube side through the pores is 
extraordinary. Here in the studies using anti-solvent crystallization, the rapid local addition 
of the anti-solvent through every pore mouth in the porous hollow fibers drastically 
decreases the solubility of the drug as well as the polymer in the shell-side feed solution. A 
very high level of supersaturation is created throughout the shell-side cross section at every 
axial location in the module causing precipitation of the drug and the polymer resulting in 
the production of polymer coated drug particles. The suspension of the coated particles 
along with the excess solution and the anti-solvent are pumped out continuously from an 
outlet of the shell.     
This novel PHFAC device and the process of synthesizing polymer coated drug 
crystals has certain advantages compared to other anti-solvent crystallizers. There is an 
extraordinarily intense contacting of the anti-solvent and the feed solution everywhere in 
the shell side of the PHFAC module. Since the fractional porosity of the hollow fiber wall 
is around 0.75, a large number of hollow fibers will result in anti-solvent jets emanating 
from all of the pores in the membrane module. Therefore, almost the entire shell side will 
be subjected to an intense contacting due to the very large interfacial area created between 
the two miscible liquid streams. A very high level of supersaturation is created throughout 
the shell side resulting in very rapid crystallization of the drug molecules. The rate of 
crystallization of the drug is very rapid; however, that for the polymer is not as rapid as 




a balance between the rate at which the supersaturation is created locally, the level of 
supersaturation created, and the time allowed for the growth process to occur which is 
largely determined by the residence time of the shell-side liquid stream. 
Another advantage of the PHFAC device is the high surface area/volume ratio that 
can be achieved if there is a reasonably high packing density of the hollow fiber membranes. 
That will lead to maximization of the rate of production of the coated drug particles and 
achievement of a high product recovery rate. Furthermore, scale-up is relatively 
straightforward since the number of hollow fibers in a module can be increased or 
decreased according to the needs of production; correspondingly, the module shell diameter 
can be increased or decreased. Theoretically, the larger the number of hollow fibers in the 
tube side of the PHFAC module, the higher the rate of production. The morphology and 
dimensions of the coated drug particles are likely to remain the same if the flow rates can 
be increased in proportion to the increase in the number of hollow fibers. 
 
5.2. Materials and Methods 
5.2.1  Materials and Preparation of The Feed Solution 
Eudragit RL 100 (Mw, 150,000; a copolymer of methyl methacrylate, ethyl acrylate and 
methacrylic acid ester) was purchased from Evonik-Degussa (Parsippany, NJ). Drug 
particles of Griseofulvin (GF) were purchased from Letco (Decatur, AL) and used without 
further treatment. This drug has a solubility of 0.116 M in acetone. It is practically insoluble 
in water; at 25°C the aqueous solubility is 8.64 mg/L. Sodium dodecyl sulfate (SDS) used 
as a surfactant was obtained from Aldrich. Deionized water was used as the tube side anti-




Asheville, NC. Theses fibers are hydrophilic, allowing easy permeation of the anti-solvent 
water through the pores. 
Eudragit RL 100 polymer was selected as the coating polymer for GF. An amount 
of 2.4 g of polymer granules was first put in a glass flask containing 20 mL acetone. After 
about 1 hr when the polymer was fully dissolved, a small amount (4 mL) of the anti-solvent, 
water was added to keep the polymer solution highly sensitive to further anti-solvent 
addition. Then 0.025 g of SDS was added before the addition of GF to keep the polymer-
coated particles to be produced well dispersed. Finally, 0.55 g GF powder was added to the 
acetone solution, and after about 30 min, the solution turned from cloudy to clear indicating 
that the GF powder was fully dissolved in the solution. 
 
5.2.2  Experimental Methods 
A schematic diagram of the porous hollow fiber anti-solvent crystallization/coating setup 
for developing polymer coated GF drug particles was shown in Figure 4.3 (Chapter 4). A 
flask containing the solution of dissolved GF and polymer was placed over a magnetic 
stirrer. A peristaltic pump (Masterflex L/S model 7518-60, Cole-Parmer, Vernon Hills, IL) 
was used to first pump DI water to the tube side. Subsequently, the polymer-drug solution 
was passed into the shell side of the PHFAC module by another peristaltic pump after 2 
min. Since the other end of the tube side was blocked, water was forced to go through the 
pores in the hollow fiber membrane into the shell side. Tiny water jets from the pores of 
the hollow fibers were injected into the acetone solution of the drug and the polymer on 
the shell side generating intense mixing of the feed solution with water.  
For submicron-sized pores and nanopores, normally porous membrane-based 




immiscible liquid, indicate creation of liquid droplets of size 1-3 times the membrane pore 
size of the liquid being forced through the pores into an immiscible liquid [49 . Due to the 
miscible nature of the organic–aqueous liquid system employed here, there will be a water 
jet emanating from each pore; however, the jet will disappear quickly via dissolution. Here 
the membrane pore size range is 0.2-1.5 µm.  
The anti-solvent water can dramatically increase the supersaturation by decreasing 
the solubility of the drug as well as the polymer in the resulting solution. The tube side 
water flow rate was kept at 11 mL/min while the shell side flow rate for the drug-polymer 
solution was maintained at 6 mL/min (unless otherwise noted). This flow rate combination 
is identified as X3; other combinations used will be identified below. The pressure 
difference maintained between the shell side and tube side was 15 psi.  
Crystals of GF appeared as expected. The polymer also precipitated from the 
solution and rapidly coated the GF drug crystals. In fact, heterogeneous nucleation of the 
polymer occurred around the growing drug crystals. The suspension of coated drug 
particles was continuously flushed out through the shell-side outlet of the PHFAC module 
into a microfiltration device (Omnipore Membrane JHWP09025, PTFE, hydrophilic, 0.45 
μm, 90 mm; Millipore, Billerica, MA) to collect the coated drug particles from the slurry. 
Products were vacuum dried and subjected to various characterization steps. 
The sequence of pumping is important, since the anti-solvent water has to permeate 
through the pore first; otherwise the viscous polymer solution can permeate to the tube side 
due to a pressure difference. There are four reasons for selecting the relatively high levels 
of the flow rate levels used in most of the experiments. i.e., 11 mL/min for the tube side 




First, it is necessary to generate sufficient pressure in the tube side for DI water to permeate 
through the pores in the wall of the hollow fibers. Secondly, the velocity of the water 
streams emanating from the pores should be high enough to facilitate intensive mixing of 
the drug-polymer solution and the anti-solvent. Thirdly, after precipitation of both the drug 
particles and the polymer from the solution in the shell side, high levels of precipitation 
can create blockages in the shell side even with a relatively smooth FEP shell surface. The 
high flow rates of the incoming water streams and the acetone-based feed solution will 
flush out the coated drug particles formed, as well as any excess polymer precipitation, so 
that the module can be run continuously to maximize productivity. Lastly, the addition of 
a large excess of the anti-solvent water generated a very high level of supersaturation to 
precipitate the maximum amount of the drug and polymer.  
 
5.3 Results and Discussion 
5.3.1  Crystallization of GF Drug Particles in a PHFAC Unit w/wo Polymer 
Dry GF powder as received was first analyzed by SEM without any treatment. Figure 5.1 
(a) shows the micrograph of pure GF particles as received at a given magnification. The 
surface of these drug particles as received appears to be very rough with a non-fractal 
structure; the particle size of GF is close to 10 µm. To find out whether the PHFAC process 
affects the characteristics of the drug particles compared to the drug particles as received, 
pure GF crystals were formed using the PHFAC process without the presence of any 
polymer. Drug particles were first fully dissolved in an acetone solution in a flask under 
stirring. The solution was directly passed through the shell side of the PHFAC device 




the anti-solvent. The product was collected at the outlet in the other end on a filter paper 
and subjected to SEM characterization. 
  
(a)  (b)           
 
(c)                                                                 (d)        
 
                                  (e)                                                                                (f) 
 
Figure 5.1  SEM micrographs: (a) Pure GF drug powder as received; (b) pure GF drug 
crystals after precipitation in a PHFAC device without any polymer; (c) and (d) polymer 
coated GF drug crystals after precipitation (X3) under different magnifications; (e) 
uncoated GF sample prepared under flow-rate combination X0 (see Table 1); (f) polymer-





(g)                                                                                  (h) 
Figure 5.1  SEM micrographs: (g) and (h): SEM and STEM micrographs respectively of 
polymer-coated GF crystals after precipitation under different magnifications (X3). 
(Continued) 
 
Figure 5.1 (b) shows the SEM micrographs of pure drug particles crystallized after 
pumping through the PHFAC device without any polymer. Compared to Figure 5.1 (a) 
where the GF particle hardly shows any crystalline shape, drug particles in Figure 5.1 (b) 
have a well-defined crystal structure. The surface is a lot smoother with only some tiny 
crystals attached to it. This is because the drug was first fully dissolved in acetone (0.55 g 
GF in 20 mL acetone) and the GF particles precipitated out from the solution as a result of 
rapid solubility reduction in the PHFAC device.  
 
5.3.2  Synthesis of Eudragit-coated GF Drug Crystals in a PHFAC Module 
When the acetone solution containing both dissolved drug molecules and polymer was 
pumped through the PHFAC crystallizer with the anti-solvent water coming in from the 
tube side, it appears that the drug molecules crystallize rapidly from the solution first, and 
then the polymer precipitates and coats the drug crystals. In Figures 5.1 (c) and 5.1 (d), a 




drug particles were crystallized without the presence of any polymer, the surface 
morphology around the drug crystals also appears to be different.  
 
5.3.3  Residence Time Variation 
Residence time plays an important role in the PHFAC process since precipitation of both 
the polymer and the drug can be affected by the variation of residence time in the shell side 
of the module. Residence time can be simply altered by changing the shell-side feed 
solution flow rate. To identify the influence of the feed solution flow rate on the particle 
size distribution (PSD) of GF crystals, the solution containing the dissolved drug without 
any polymer was passed through the PHFAC module at different rates. The particle size 
distribution will also be affected by the extent of supersaturation, and the rate at which the 
anti-solvent is introduced from the tube side to the shell side for a given feed solution flow 
rate. 
  Results of the PSD of the drug crystals under different combinations of flow rates 
of the two streams (X0, X1, X2, X3 and X4) are listed in Table 5.1. The combination X0 
has the lowest tube side anti-solvent flow rate and the highest shell-side feed flow rate, 
which reduces the level of interaction between the feed and the anti-solvent to the lowest 
level. As a result, it has the lowest extent of supersaturation and rate of supersaturation 
development and the median particle size of drug crystals is only 1.61 μm (Figure 5.1 (e)). 
Also, the recovery rate of the drug crystals is the lowest among all five conditions since 
most of the drug was still dissolved in the solution without precipitation. If we keep the 
tube side anti-solvent flow rate at the same level but decrease the shell-side feed solution 
flow rate to 6 mL/min (combination X2), the median particle size increased to 7.33 μm. 




crystal growth time and consumption of the supersaturation created. Combination X1 has 
a larger residence time than that in X0 but smaller than that in X2. As a result the average 
particle size is intermediate between those from combinations X0 and X2. 
 
Table 5.1  The PSDs of Drug Crystals from PHFAC Module Without Any Polymer in the 




Shell side flow 
rate (mL/min) 




d10 (μm) d90 (μm) 
X0 11 6 1.61 1.00 2.21 
X1 8.5 6 3.95 1.70 16.16 
X2 6 6 7.33 1.87 15.29 
X3 6 11 11.83 2.11 30.30 
X4 12 11 11.76 2.94 26.62 
 
For flow combinations of X3 and X4, the tube side anti-solvent flow rate was 
increased from 6 to 11 mL/min giving rise to intensive mixing of the feed solution with the 
anti-solvent resulting in rapid development of very high levels of supersaturation. When 
comparing the combination X4 with the combination X3, it appears that in spite of doubling 
the shell side feed flow rate, the median size of particles still remained essentially the same. 
It is possible that with such a high tube side flow rate, the rate of supersaturation 
development and the growth rates are high enough to allow for ample growth of the drug 
particles. Further, the shell–side residence time variation employed was not high enough 
to affect the final PSD of the drug particles. In addition, it appears that the drug was fully 
precipitated from the solution and grew to its maximum size. 
It is clear that the drug crystal size can be altered by variation of both the feed 
solution flow rate and the tube-side anti-solvent flow rate. Polymer coating experiments 




controlled by varying the residence time, the drug crystals can still be coated with polymer 
that precipitated in the PHFAC module. Figure 5.1 (e) shows an SEM micrograph of 
uncoated crystals prepared under the flow-rate combination X0 involving the smallest 
residence time and the lowest extent of supersaturation (Table 5.1), while Figure 5.1 (f) 
shows the SEM micrograph of a coated GF crystal obtained under the combination X2 
(Table 5.1). Figures 5.1 (g) and 5.1 (h) illustrate the thickness of the polymer coating on 
the crystals at two levels of magnification. The flow combination of X3 was employed for 
these samples. Figure 5.1 (h) based on a higher magnification has a scale length of 20 nm; 
one can clearly observe a coating of around 20 nm thickness around the crystal. Figure 5.1 
(g) shows the scale bar length is 2 µm. But one can still see a thin coating, about 20 nm, 
around the crystal. 
It is important to know the sequence of precipitation and extent of co-precipitation 
if any of the drug and the polymer when introducing the anti-solvent from the tube side of 
the PHFAC module. If the drug particles precipitate/crystallize first, then the final product 
is most likely to be polymer-coated drug particles. However if both the drug and the 
polymer crystallize or precipitate at the same time, the product will be either the drug 
dispersed in a polymeric matrix or vice versa. To explore these concepts, an experiment 
was run under the flow-rate combination of X2 (Table 5.1) with the acetone solution on the 
shell side containing only Eudragit RL 100 polymer; the drug GF was not present in the 
feed solution.  
After the PHFAC process was completed, no polymer precipitate was collected on 
the filter paper from the module outlet. This suggested that the rate of polymer precipitation 




of anti-solvent induced supersaturation created in this experiment. Thus the polymer 
appears to precipitate rapidly only in the presence of crystals of drug particles which serve 
as nuclei for polymer crystallization. As a result, when the polymer solution containing 
dissolved drug molecules is pumped into the PHFAC unit, the drug crystals precipitate out 
of the solution first and then the polymer precipitates and coats the GF particles as 
described above  
 
5.3.4  Particle Size Distribution  
Since one of the objectives of the study is to understand the impact of this novel PHFAC 
coating technique on the synthesized drug particles, both the as-received uncoated GF 
particles and the Eudragit-coated GF particles obtained from the PHFAC were selected for 
particle size distribution analysis. A suspension of the samples in water was carefully 
dropped into the inlet of the laser diffraction particle size analyzer. Results of the two 
samples are shown in Figure 5.2. The median size of the uncoated GF sample (11.6 μm) 
was close to the manufacturer’s specification (10 μm). After polymer coating, the median 
size of the coated drug particles increased to 19.2 μm. One reason for the median size 
increase is obviously due to the coating which increases the particle size. A more relevant 
reason is that the coating of GF by the polymer results in a certain amount of agglomeration. 
Attachment of neighboring coated drug particles will take place due to the sticking 





Figure 5.2  Particle size distribution for uncoated GF and coated GF under PHFAC. 
 
5.3.5  TGA Characterization of Polymer Coated Drug Particles 
TGA analysis was used to determine the percent weight loss of the sample as a function of 
increasing temperature. In order to measure the weight of the polymer coating (and thus 
the thickness of the coating) for polymer coated drug particles, it is necessary to identify 
the different temperature ranges over which weight loss is caused by both drug 
decomposition and polymer decomposition as the sample is heated in the TGA. 
A small amount of pure GF particles was placed in a hang down pan inside the 
TGA analyzer and the temperature was increased from 25 oC to 550 oC at a rate of 10 
oC/min. In Figure 5.3 (a), the blue line shows the TGA result for an as-received GF sample. 
The drug will start decomposing when heated up with all of the weight loss occurring 






                                                                   (a) 
 
 
                                                           (b) 
Figure 5.3  TGA results of (a) as-received GF and coated GF particles; (b) polymer coated 
silica particles. 
 
Figure 5.3 (b) is a typical TGA result for Eudragit RL 100 coated silica particles 
taken from Figure 2.13. Since silica particles do not decompose even when the temperature 
goes up to 550 oC, the percent weight loss is due to the loss of the polymer. Thus the 










































Therefore, the overlapping temperature range of the drug and polymer 
decomposition is from about 150 to 270 oC. The total polymer weight loss can be divided 
into two parts: the weight loss in the range from 150 to 270 oC and the weight loss in the 
range from 270 to 550 oC. From Figure 5.3 (b) the polymer weight loss in the range of 150-
270 oC is about 2 %, whereas the weight loss in the range of 270-550 oC is about 10 %.  
For the polymer-coated drug (red-dot curve in Figure 5.3 (a)), one can assume that 
the polymer-based weight loss of the sample from 150 to 270 oC will be also be about 2%. 
From Figure 5.3 (a), the weight loss of the polymer coated sample between 270 to 550 oC 
is about 10%. Therefore, the total weight loss of the polymer over the entire temperature 
range can be estimated by adding the 2% weight loss of the polymer in the temperature 
range 150 to 270 oC to the 10% weight loss observed for the polymer coated drug shown 
by the red-dot curve in Figure 5.3 (a) in the temperature range of 270 to 550 oC. Thus it 
can be estimated that about 12% of the weight loss of the sample was due to the 
decomposition of the polymer coating over the drug particles. 
To estimate the thickness of the polymer coating, one assumes that every drug 
crystal is a rectangular parallelepiped having dimensions Hdrug, Wdrug and Ldrug with a 
polymer coating of uniform thickness h covering the entire drug crystal. The equation 
governing the relationship between the mass of the polymer coating and the mass of the 
drug particle is obtained from equation (3.1). The densities of the drug particles and 
polymer are ρdrug (1.4 g/ml) and ρpolymer (1.1 g/ml), respectively. The length, width and 
height of the drug crystals are estimated to be 10 μm, 2 μm, and 2 μm based on SEM 




ratio mdrug/mpolymer is equal to 8.34 (=1/0.12). Using equation 3.1, the polymer coating 
thickness, h, was estimated from the equation to be 0.075 μm or 75 nm.  
 The most likely reason why this estimate of the coating thickness is considerably 
higher than the observed thickness measured by STEM analysis in Figure 5.1 (h) is the 
following. It has been already observed from Figure 5.3 that there is a certain amount of 
agglomeration in the coated crystals with around two crystals joining together. The 
considerable amount of polymer present in the bridges between two crystals is not taken 
into account by equation (3.1) which is based on the total mass of polymer present as 
measured by the TGA. This essentially increases the estimated thickness around a single 
particle assumed to be uniformly coated around its perimeter. Further, there will be 
variations in thickness around a crystal whereas Figure 5.1 (h) shows only a particular 
location. 
 
5.3.6  XRD and Raman Results 
Flattened powder formats of the uncoated GF crystals and polymer coated GF crystals were 
prepared and analyzed by XRD to identify whether the coating of the drug crystals by the 
PHFAC process will damage the crystal structure of GF. As can be seen from the XRD 
results in Figure 5.4 (a), both uncoated and coated GF patterns show no alteration in the 
peak position. The characteristic peaks of both samples are identical. Figure 5.4 (b) 
illustrates the Raman spectra results for uncoated and coated GF crystals at the Raman shift 
range from 0 to 4000 cm-1. Identical peaks for both uncoated GF and the polymer-coated 
GF proved that during the anti-solvent crystallization process, even though the GF drug 




the polymer, the molecular structure remained intact. Raman spectra were in accordance 







Figure 5.4  (a) X-ray diffractograms of uncoated GF and coated GF samples; (b). Raman 





































5.3.7  Differential Scanning Calorimetry 
DSC patterns for as-received GF and the polymer-coated GF are shown in Figure 5.5. In 
the thermogram, the peak starting position implied that the melting point of as-received GF 
is 219.97 oC. This peak position is comparable to the pattern for polymer coated GF which 
has the value of 219.22 oC. The intensity difference may be attributed to the coating 
covering the drug particles; it is likely to attenuate the signal strength. The very close, 
almost identical, positions of the peaks in both the XRD and DSC diagrams suggest that 
the polymer coating by the anti-solvent crystallization process did not alter the crystallinity 




Figure 5.5  Differential scanning calorimetry patterns for uncoated GF and coated GF. 
 
5.3.8  Dissolution Testing 
To illustrate the advantages of a coated drug for controlled release, dissolution tests were 
performed on three samples: as-received drug, uncoated drug, and polymer coated drug. 



























37 oC. GF has very limited solubility in water; it will take more than 2 hours to dissolve the 
drug particles. SDS was added to facilitate dissolution and the time needed to dissolve it. 
Figure 5.6 shows the dissolution profiles for the three samples up to 50 minutes. The as-
received and uncoated GF show very similar dissolution curves indicating that even after 
being pumped through the PHFAC device and crystallized by the PHFAC process, 
uncoated GF crystals will still dissolve with time in almost the same manner as the as-
received drug. On the other hand, the polymer coated GF dissolved only about 20% after 




Figure 5.6  Dissolution profiles for crystals of as-received GF, uncoated GF, and polymer 
































GENERAL CONCLUSIONS AND RECOMMENDATION FOR FUTURE 
STUDIES 
 
6.1  Summary 
Currently, no technique is available to continuously film coat nano-sized drug particles 
with a polymer to produce large amounts of free-flowing coated particles. Continuous 
polymer coating of nanoparticles is of interest in many industries such as, pharmaceuticals, 
cosmetics, food, and electronics. In this thesis, two novel crystallization methods, SHFCC 
and PHFAC, have been developed to coat the host particles in a continuous basis. 
Chapters 2 and 3 introduced a novel SHFCC crystallizer/heat exchanger that was 
utilized to continuously coat silica particles with a polymer as well as continuously 
synthesize GF drug particles coated with polymers from a solution of the drug and the 
polymer which contained dissolved drug molecules. The cloud point of the polymer 
solution was determined by UV spectrophotometry for the polymer-solvent-nonsolvent 
systems of Eudragit RL100/acetone/water and PLGA/dioxane/water. After determining the 
cloud point of the polymer solutions, the solid hollow fiber cooling crystallization (SHFCC) 
technique was adapted to continuously coat host particles with the polymer. In this method 
the polymer solution containing a suspension of submicron particles or nanoparticles flow 
in the lumen of a solid polymeric hollow fiber. Controlled cooling of the polymer solution 
by a coolant on the shell side of the hollow fibers allows for polymer nucleation on the 
surface of the particles; the precipitated polymer forms a thin film around the particles, the 
thickness of which can be varied depending on the operating conditions. Scanning electron 




spectrometry (EDS), laser diffraction spectroscopy (LDS), thermogravimetric analysis 
(TGA), X-Ray Diffraction (XRD), Raman spectroscopy, and dissolution testing were all 
used to characterize the coatings. The results indicate that a uniformly coated and free-
flowing product can be achieved under optimized conditions in the SHFCC and suitable 
post-treatments. This novel crystallization/coating method should be attractive for polymer 
coating of nanopharmaceuticals since scale-up is relatively simple and coated particles can 
be mass produced continuously.  
Chapter 4 introduces a facile anti-solvent crystallization method to continuously 
coat submicron and nano-sized particles using a porous hollow fiber membrane (PHFAC) 
device. Submicron (550 nm) and nano-sized (12 nm) silica particles were selected as the 
host particles; Eudragit RL 100 and PLGA were used as coating polymers. A suspension 
of the silica particles in an acetone solution of the polymer used for coating was 
continuously pumped through the shell side of a hollow fiber membrane module. The anti-
solvent (water) flowing in the hollow fiber lumen was forced through the membrane pores 
into the shell side liquid generating intense mixing with the flowing suspension. This led 
to rapid precipitation of the polymer and coating of the particles. Coated silica particles 
collected in a vacuum filtration device were analyzed after vacuum drying using a variety 
of characterization tools. These results indicate that a polymer coating of the silica particles 
can be developed by this novel PHFAC method. Further, two widely different polymers 
were used to coat silica-based submicron particles as well as nanoparticles. This continuous 
method based on the porous hollow fiber membrane containing modules appears to be 




Chapter 5 focuses on continuous synthesis of polymer coated GF drug particles by 
a PHFAC device. In such a device, the anti-solvent water flowing through the lumen of 
porous hollow fibers is introduced through the pores in the wall of the hollow fibers into 
the shell side where an acetone solution of the drug GF and the polymer Eudragit is flowing. 
The intense mixing created by the anti-solvent streaming jets into the feed acetone solution 
generates very high supersaturation throughout the solution flowing in the shell side. This 
causes drug crystals to appear very rapidly; subsequently each GF crystal is coated by a 
thin layer of the precipitating polymer undergoing nucleation around each GF crystal 
surface leading to polymer coated drug crystals.  
A variety of analytical techniques were used to characterize the polymer coated 
drug particles obtained. It was demonstrated that by applying the PHFAC method one can 
obtain uniform and free-flowing coated drug particles. Results from XRD and Raman 
spectra and DSC measurements suggest that the polymer coating did not alter the molecular 
structure of the drug. Controlled release of the drug inside of the coating was demonstrated 
by drug dissolution tests which showed that less than 20% of the drug dissolved after 50 
minutes. The process can be scaled up by increasing the number of porous hollow fibers 
and the shell-side diameter, while maintaining the shell-side residence time of the feed 
solution and the ratio of the feed flow rate to the anti-solvent flow rate so as to obtain coated 
drug particles having similar morphology and polymer coating thickness. Different 
variations of this technique may be implemented, including introducing the drug and the 
polymer through two different streams. Furthermore, by changing the material of the host 
particle and coating polymer, this novel PHFAC technique can be utilized in the production 




The concentration of the drug in the feed will influence the level of supersaturation 
created by the antisolvent and therefore the rate and extent of drug 
nucleation/crystallization. Lower concentrations will lead to lower rates of supersaturation 
development and potentially lower rates of growth, and therefore smaller numbers of 
smaller crystals. If the polymer concentration is too low and/or the polymer precipitation 
rate is too slow, the coverage of the crystal surfaces may be compromised. The behavior 
of any drug-polymer-solvent-anti-solvent system will need to be evaluated on an individual 
basis. It is also necessary to study the stability of such coated crystals in physiological 
environment and over time. 
Although the PHFAC technique has been illustrated using GF, a commonly studied 
antifungal drug, there does not appear to be any limitation to using other drugs. The drug 
particle sizes can be varied over a wide range by varying the residence time of the feed 
solution and the relative flow rates of the two streams.  
In conclusion, with the novel SHFCC and PHFAC crystallization devices provide 
two different ways to continuous coat the drug particles with different polymers. SHFCC 
is extremely useful when the solubility of the coating polymer is sensitive to the 
temperature change, but the coating efficiency might be less than that of PHFAC since 
normally the polymer cannot precipitate entirely from the solution due to the temperature 
reduction. PHFAC can be used in those circumstances where the coating polymer is 
sensitive to the anti-solvent but the control over the precipitation might be weaker than that 
through SHFCC method.  One can choose to apply either crystallization technique to coat 
the drug particles depending on different conditions and requirements. They are both 




compared to conventional coating techniques; thus  the possibility of applying these 
continuous polymer coating techniques in the production of polymer-coated cosmetics, 
food, fertilizers, agricultural seeds and pharmaceuticals look promising. 
 
6.2  Suggested Future Work 
Future efforts should first focus on the development of these two techniques to coat a 
variety of drug particles by different polymers in order to prove the universality of the 
methods and devices. By the modification of pre-treatments such as the host particles 
addition, temperature, ratio of solvent to anti-solvent, etc, one can precisely control the 
coating morphology and thickness. Systematic development of a model for both SHFCC 
and PHFAC process will also be helpful for a study of these two novel techniques. Using 
appropriate simulations, one can not only predict the coating thickness and distribution of 

















A.1  Calculation of the Coating Thickness of the Submicron Silica Particles From 
TGA Analysis 
Figure A.1 shows the process of uncoated silica particles to those being coated by polymer 
after the crystallization of polymer.  
For single uncoated silica particles shown in Figure A.1 (a), the mass of silica particles can 
be written as 
34
3
SilicaSilica rm    , 
For polymer coated silica particles shown in Figure A. 1 (b), the mass of polymer that 
covered the silica particles can be written as 
3 34 {(r h) }
3
PolymePolymer r rm     , 
where r is the radius of as-received silica (for submicron silica, r = 275 nm) and h is the 
polymer coating thickness. mSilica and mPolymer are the mass of the particles and polymer, 
respectively. The densities of the host particles and polymer are ρSliica (=2.65 g/ml) and 
ρPolymer (=1.1 g/ml). Theoretically the ratio of silica to polymer can be interpreted as 



















   
                                    (2.1) 
To calculate the polymer coating thickness, the ratio of polymer to silica has to be first 
identified by TGA analysis listed in Figure 2.13. Since uncoated silica particles do not 




decomposition of the polymer coated on the particles.  The actual ratio of the mass of 
polymer to silica from TGA results should be equal to the theoretical ratio of polymer to 















































the polymer coating thickness for the submicron particles h is found to be 33 nm.  
 
 
(a)                                                                    (b) 
Figure A.1  Schematic of coating process of silica particles: (a) uncoated silica particles; 











PRELIMINARTY MODELLING OF THE CRYSTALLIZATION PROCESS 
 
B.1 Predication of Coating Thickness Along the Hollow Fiber Length in A SHFCC 
Module 
In the SHFCC module, the polymer first precipitated from the solution due to the rapid 
temperature reduction of the shell side, and subsequently coated the silica particles in the 
tube side. The supersaturation is related to the kinetics of the system in which the solute 






                                                               (B.1) 
Here A represent the total surface area of host particles, G is the growth kinetics and Rb is 
the nucleation rate. Since the nucleation rate is relatively small (A*G>>Rb[50]), G=kg
Cg, and equation B. 1 can be interpreted as follows: 
( *)g gg g
Solvent Solvent
dC A A
k C k C C
dt M M
                                       (B.2) 
where MSolvent is the molar mass of the solvent, C is the polymer concentration in solution, 
C* is the solubility of the polymer, Since C* corresponds to the temperature T, and T has 
a essentially linear relationship with fiber length Z. So assume the relationship between C* 
and Z is C*= f (Z).   
For the left side of the equation,  
dC dC dZ dC
v
dt dZ dt dZ
     
Where Z is the length of the hollow fiber, v is the axial average velocity of the flow in the 









    
Since all the coefficients (kg, MSolvent, v, A, g) can be calculated from the boundary 
conditions, thus one can predict the polymer coating thickness (using the polymer 
concentration C) as a function of various hollow fiber length (Z) from the equation. 
 
B.2 Predication of Coating Thickness by the Variation of Silica Addition 
The surface area of single silica ball can be written as 
24SingleA r  
The number of silica particles can be assumes in the following if assuming 
Silicam  as the 
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    
Integration of the equation, 
                        
1 3 3( *)
1
g
g Silica g Silica
Silica Solvent Silica Solvent
k m k mC C Z
t D D
g rM rM v 

    

  
Thus one can predict the polymer coating thickness (using polymer concentration C) since 
it’s a function of silica addition 




B.3 Predication of Coating Efficiency of SHFCC and PHFAC Processes 
SHFCC 
For polymer coating of silica submicron particles (550 nm) by SHFCC method, since the 
coating thickness h= 33 nm by TGA results and the actual silica addition is 2.4 g. So the 

















mPolymer= 0.07 g. Since the actual polymer addition is 2.4 g, the coating efficiency can then 
be calculated as 0.07/2.4= 3%. 
 
PHFAC 
For polymer coating of silica submicron particles (550 nm) by PHFAC method, since the 
coating thickness h= 33 nm by TGA results and the actual silica addition is 2.4 g. So the 

















mPolymer= 0.235 g. Since the actual polymer addition is 0.6 g, the coating efficiency can 
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